41 results on '"M. Mazzoni"'
Search Results
2. Blend of natural and natural identical essential oil compounds as a strategy to improve the gut health of weaning pigs
- Author
-
D. Luise, F. Correa, C. Negrini, S. Virdis, M. Mazzoni, S. Dalcanale, and P. Trevisi
- Subjects
Cinnamaldehyde ,E. coli ,Microbiota ,Postweaning ,Zinc oxide ,Animal culture ,SF1-1100 - Abstract
Weaning is one of the most critical phases in pig’s life, often leading to postweaning diarrhoea (PWD). Zinc oxide (ZnO), at pharmacological doses, has been largely used to prevent PWD; however, due to antimicrobial co-resistant and environmental pollution issues, the EU banned its use in June 2022. Natural or natural identical components of essential oils and their mixture with organic acids are possible alternatives studied for their antimicrobial, anti-inflammatory and antioxidant abilities. This study aimed to evaluate the effect of two blends of natural or natural identical components of essential oils and organic acids compared to ZnO on health, performance, and gut health of weaned pigs. At weaning (d0), 96 piglets (7 058 ± 895 g) were assigned to one of four treatments balanced for BW and litter: CO (control treatment), ZnO (2 400 mg/kg ZnO from d0 to d14); Blend1 (cinnamaldehyde, ajowan and clove essential oils, 1 500 mg/kg feed); Blend2 (cinnamaldehyde, eugenol and short- and medium-chain fatty acids, 2 000 mg/kg feed). Pigs were weighed weekly until d35. Faeces were collected at d13 and d35 for microbiota (v3–v4 regions of the 16 s rRNA gene) and Escherichia coli (E. coli) count analysis. At d14 and d35, eight pigs/treatment were slaughtered; pH was recorded on intestinal contents and jejunal samples were collected for morphological and gene expression analysis. From d7–d14, the Blend2 had a lower average daily gain (ADG) than CO and ZnO (P
- Published
- 2023
- Full Text
- View/download PDF
3. Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma
- Author
-
M. Mazzoni, K. Todoerti, L. Agnelli, E. Minna, S. Pagliardini, T. Di Marco, M. G. Borrello, A. Neri, and A. Greco
- Subjects
TIMP3 ,Thyroid carcinoma ,Inflammation ,Gene expression ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Cytology ,QH573-671 - Abstract
Abstract Background Papillary thyroid cancer (PTC) is the most frequent thyroid tumor. The tissue inhibitor of metalloproteinase-3 (TIMP3) gene encodes a matrix metalloproteinases inhibitor that exerts a tumor suppressor role in several tumor types. TIMP3 is frequently downregulated in PTC by promoter methylation. We have previously functionally demonstrated that TIMP3 exerts an oncosuppressor role in PTC: TIMP3 restoration in the PTC-derived NIM1 cell line affects in vitro migration, invasion and adhesive capability, while reduces tumor growth, angiogenesis and macrophage recruitment in vivo. To get a deeper insight on the mediators of TIMP3 oncosuppressor activity in thyroid tumors, here we focused on the TIMP3 related transcriptome. Methods TCGA database was used for investigating the genes differentially expressed in PTC samples with low and high TIMP3 expression. Genome wide expression analysis of clones NIM1-T23 (expressing a high level of TIMP3 protein) and NIM1-EV (control empty vector) was performed. Gene sets and functional enrichment analysis with clusterProfiler were applied to identify the modulated biological processes and pathways. CIBERSORT was used to evaluate the distribution of different immunological cell types in TCGA-PTC tumor samples with different TIMP3 expression levels. Real time PCR was performed for the validation of selected genes. Results Thyroid tumors with TIMP3-high expression showed a down-modulation of inflammation-related gene sets, along with a reduced protumoral hematopoietic cells fraction; an enrichment of cell adhesion functions was also identified. Similar results were obtained in the TIMP3-overexpessing NIM1 cells in vitro model, where a down-regulation of immune-related function gene sets, some of which also identified in tumor samples, was observed. Interestingly, through enrichment analysis, were also recognized terms related to cell adhesion, extracellular matrix organization, blood vessel maintenance and vascular process functions that have been found modulated in our previous in vitro and in vivo functional studies. Conclusions Our results highlight the correlation of TIMP3 expression levels with the regulation of inflammatory functions and the immune infiltration composition associated with different PTC prognosis, thus providing a broader view on the oncosuppressor role of TIMP3 in PTC.
- Published
- 2022
- Full Text
- View/download PDF
4. Effect of an Escherichia coli F4/F18 bivalent oral live vaccine on gut health and performance of healthy weaned pigs
- Author
-
F. Correa, D. Luise, L. Amatucci, F. Palumbo, S. Virdis, C. Negrini, P. Clavenzani, M. Vecchi, M. Mazzoni, P. Bosi, and P. Trevisi
- Subjects
Blood cell formula ,Claudin ,Microbiota ,Swine ,Weaning ,Animal culture ,SF1-1100 - Abstract
Oral live vaccines stimulate host immunity, but they could also affect intestinal mucosa development and gut microbiota of piglets during the postweaning. The aim of this study was to determine the effect of an oral vaccine against Escherichia coli F4 and F18 (Coliprotec F4/F18®), on gut functionality and integrity, growth performance and health status of postweaning piglets. A total of 96 weaned piglets (23.30 ± 1.85 days of age; 7334 ± 1039 g BW) were divided into two groups (16 replicates/group; three piglets/replicate) as follows: (1) Control (CO), fed a standard diet (prestarter up to 14 days, then starter feed); (2) Treated (TRT): as CO but vaccinated with Coliprotec F4/F18® at weaning (day 0). Piglets were weighed at day 0 and weekly until day 35. Individual faecal score was recorded daily. Piglets were sacrificed at days 10 (1/3 of total) and 35 (2/3). Samples of jejunum mucosa and of cecum content were collected for morphometric, immunohistochemistry analysis and for microbiota profile analysis, respectively. Data were fitted using a linear model including treatment, class of starting BW as fixed factors and litter as random factor. From days 0 to 7, piglets from the TRT group tended to have a higher average daily gain (+22.6%, P = 0.08) and average daily feed intake compared to the CO group (+13.2%, P = 0.022). Gain to feed ratio was lower in the TRT group from days 14 to 35 (−6.6%, P = 0.011). From days 7 to 14, the TRT group had a higher diarrhoea index (−199%, P
- Published
- 2022
- Full Text
- View/download PDF
5. Effect of chronic heat stress on gastrointestinal histology and expression of feed intake-regulatory hormones in broiler chickens
- Author
-
M. Mazzoni, M. Zampiga, P. Clavenzani, G. Lattanzio, C. Tagliavia, and F. Sirri
- Subjects
Appetite regulation ,Climate change ,Enteroendocrine cell ,Poultry ,Thermal stress ,Animal culture ,SF1-1100 - Abstract
Heat stress (HS) dramatically impairs the growth performance of broiler chickens, mainly as a consequence of reduced feed intake due to the loss of appetite. This study was aimed at evaluating the alterations induced by chronic HS conditions on the morphological and morphometric features of the gastrointestinal (GI) tract and on the expression of some enteroendocrine cells (EECs) involved in the regulation of feed intake in chickens. Three hundred male chickens (Ross 308) were divided into two experimental groups and raised either in thermoneutral environment for the whole fattening period (0–41 days) (TNT group) or subjected to chronic HS conditions (30 °C for 24 h/day) from 35 to 41 days (HS group). Samples of proventriculus, duodenum, jejunum and cecum were collected from 24 broilers (12/group). Haematoxylin-eosin was used for the morphometric evaluations, while immunohistochemistry was applied for the evaluation of EECs expressing ghrelin (GHR), cholecystokinin (CCK), neuropeptide Y (NPY), glucagon-like peptide-1 (GLP-1), and serotonin (5-HT). In the proventriculus, HS reduced total wall thickness and mucous layer height (P ≤ 0.01) as well as mean diameter, circumference, and area of the compound tubular glands (P ≤ 0.001) with respect to TNT. The small intestine of HS birds was characterised by decreased villous height and total thickness (duodenum, P ≤ 0.01; jejunum, P ≤ 0.001), whereas crypt depth and width were reduced only in the jejunum (P ≤ 0.01). HS had negligible effects on the morphological aspects of the cecum. In the proventriculus, an increase in GHR and NPY EECs was observed in response to HS (P ≤ 0.001). Similarly, the small intestine villi of the HS group showed greater GLP-1 (P ≤ 0.05), 5-HT (P ≤ 0.001) and CCK (P ≤ 0.01) EECs. Moreover, the expression of 5-HT EECs was higher in the duodenal (P ≤ 0.01) and jejunal (P ≤ 0.01) crypts of HS birds, whereas GLP-1 and CCK EECs increased only in jejunal crypts (P ≤ 0.05). Finally, 5-HT EEC expression was increased in the cecum of HS group (P ≤ 0.01). In conclusion, these outcomes demonstrate that chronic HS induces morphometric alterations not only in the small intestine but also in a key organ such as the proventriculus. Furthermore, HS conditions affect the presence and distribution of EECs, suggesting that some GI peptides and biogenic amine may be implicated in the regulation of appetite and voluntary feed intake in heat-stressed broiler chickens.
- Published
- 2022
- Full Text
- View/download PDF
6. Auxin Interactions with Other Hormones in Plant Development
- Author
-
Javier Brumos, Chengsong Zhao, Jose M. Alonso, Serina M. Mazzoni-Putman, and Anna Stepanova
- Subjects
chemistry.chemical_classification ,Indoleacetic Acids ,fungi ,food and beverages ,Plant Development ,Endogeny ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Cell biology ,chemistry.chemical_compound ,Crosstalk (biology) ,Plant development ,chemistry ,Plant Growth Regulators ,Auxin ,Gibberellic acid ,Abscisic acid ,Salicylic acid ,Hormone - Abstract
Auxin is a crucial growth regulator that governs plant development and responses to environmental perturbations. It functions at the heart of many developmental processes, from embryogenesis to organ senescence, and is key to plant interactions with the environment, including responses to biotic and abiotic stimuli. As remarkable as auxin is, it does not act alone, but rather solicits the help of, or is solicited by, other endogenous signals, including the plant hormones abscisic acid, brassinosteroids, cytokinins, ethylene, gibberellic acid, jasmonates, salicylic acid, and strigolactones. The interactions between auxin and other hormones occur at multiple levels: hormones regulate one another's synthesis, transport, and/or response; hormone-specific transcriptional regulators for different pathways physically interact and/or converge on common target genes; etc. However, our understanding of this crosstalk is still fragmentary, with only a few pieces of the gigantic puzzle firmly established. In this review, we provide a glimpse into the complexity of hormone interactions that involve auxin, underscoring how patchy our current understanding is.
- Published
- 2023
7. Prompt D-0, D+, and D*(+) production in Pb-Pb collisions at root S-NN=5.02 TeV
- Author
-
Acharya, S. Adamova, D. Adler, A. Adolfsson, J. Rinella, G. Aglieri Agnello, M. Agrawal, N. Ahammed, Z. Ahmad, S. and Ahn, S. U. Ahuja, I Akbar, Z. Akindinov, A. and Al-Turany, M. Alam, S. N. Aleksandrov, D. Alessandro, B. and Alfanda, H. M. Alfaro Molina, R. Ali, B. Ali, Y. Alici, A. Alizadehvandchali, N. Alkin, A. Alme, J. Alt, T. and Altsybeev, I Anaam, M. N. Andrei, C. Andreou, D. and Andronic, A. Angeletti, M. Anguelov, V Antinori, F. and Antonioli, P. Anuj, C. Apadula, N. Aphecetche, L. and Appelshaeuser, H. Arcelli, S. Arnaldi, R. Arsene, I. C. and Arslandok, M. Augustinus, A. Averbeck, R. Aziz, S. Azmi, M. D. Badala, A. Baek, Y. W. Bai, X. Bailhache, R. and Bailung, Y. Bala, R. Balbino, A. Baldisseri, A. Balis, B. Banerjee, D. Barbera, R. Barioglio, L. Barlou, M. and Barnafoldi, G. G. Barnby, L. S. Barret, V Bartels, C. and Barth, K. Bartsch, E. Baruffaldi, F. Bastid, N. Basu, S. and Batigne, G. Batyunya, B. Bauri, D. Alba, J. L. Bazo and Bearden, I. G. Beattie, C. Becht, P. Belikov, I and BellHechavarria, A. D. C. Bellini, F. Bellwied, R. and Belokurova, S. Belyaev, V Bencedi, G. Beole, S. Bercuci, A. Berdnikov, Y. Berdnikova, A. Bergmann, L. Besoiu, M. G. Betev, L. Bhaduri, P. P. Bhasin, A. Bhat, I. R. and Bhat, M. A. Bhattacharjee, B. Bhattacharya, P. Bianchi, L. and Bianchi, N. Biernat, J. Bilandzic, A. Biro, G. and Biswas, S. Blair, J. T. Blau, D. Blidaru, M. B. Blume, C. Boca, G. Bock, F. Bogdanov, A. Boi, S. Bok, J. and Boldizsar, L. Bolozdynya, A. Bombara, M. Bond, P. M. and Bonomi, G. Borel, H. Borissov, A. Bossi, H. Botta, E. and Bratrud, L. Braun-Munzinger, P. Bregant, M. Broz, M. and Bruno, G. E. Buckland, M. D. Budnikov, D. Buesching, H. and Bufalino, S. Bugnon, O. Buhler, P. Buthelezi, Z. Butt, J. B. Bylinkin, A. Bysiak, S. A. Cai, M. Caines, H. and Caliva, A. Villar, E. Calvo Camacho, J. M. M. Camacho, R. S. and Camerini, P. Canedo, F. D. M. Carnesecchi, F. Caron, R. and Castellanos, J. Castillo Casula, E. A. R. Catalano, F. and Sanchez, C. Ceballos Chakraborty, P. Chandra, S. Chapeland, S. Chartier, M. Chattopadhyay, S. Chattopadhyay, S. and Chauvin, A. Chavez, T. G. Cheng, T. Cheshkov, C. and Cheynis, B. Barroso, V. Chibante Chinellato, D. D. Cho, S. and Chochula, P. Christakoglou, P. Christensen, C. H. and Christiansen, P. Chujo, T. Cicalo, C. Cifarelli, L. and Cindolo, F. Ciupek, M. R. Clai, G. Cleymans, J. and Colamaria, F. Colburn, J. S. Colella, D. Collu, A. and Colocci, M. Concas, M. ConesaBalbastre, G. del Valle, Z. Conesa Contin, G. Contreras, J. G. Coquet, M. L. and Cormier, T. M. Cortese, P. Cosentino, M. R. Costa, F. and Costanza, S. Crochet, P. Cruz-Torres, R. Cuautle, E. and Cui, P. Cunqueiro, L. Dainese, A. Danisch, M. C. Danu, A. Das, P. Das, P. Das, S. Dash, S. De Caro, A. and de Cataldo, G. DeCilladi, L. de Cuveland, J. De Falco, A. and De Gruttola, D. De Marco, N. De Martin, C. De Pasquale, S. Deb, S. Degenhardt, H. F. Deja, K. R. Dello Stritto, L. Deng, W. Dhankher, P. Di Bari, D. Di Mauro, A. and Diaz, R. A. Dietel, T. Ding, Y. Divia, R. Dixit, D. U. and Djuvsland, O. Dmitrieva, U. Do, J. Dobrin, A. and Doenigus, B. Dubey, A. K. Dubla, A. Dudi, S. Dupieux, P. and Dzalaiova, N. Eder, T. M. Ehlers, R. J. Eikeland, V. N. and Eisenhut, F. Elia, D. Erazmus, B. Ercolessi, F. and Erhardt, F. Erokhin, A. Ersdal, M. R. Espagnon, B. and Eulisse, G. Evans, D. Evdokimov, S. Fabbietti, L. and Faggin, M. Faivre, J. Fan, F. Fantoni, A. Fasel, M. and Fecchio, P. Feliciello, A. Feofilov, G. Fernandez Tellez, A. and Ferrero, A. Ferretti, A. Feuillard, V. J. G. Figiel, J. and Filchagin, S. Finogeev, D. Fionda, F. M. Fiorenza, G. and Flor, F. Flores, A. N. Foertsch, S. Fokin, S. and Fragiacomo, E. Frajna, E. Fuchs, U. Funicello, N. and Furget, C. Furs, A. Gaardhoje, J. J. Gagliardi, M. Gago, A. M. Gal, A. Galvan, C. D. Ganoti, P. Garabatos, C. and Garcia, J. R. A. Garcia-Solis, E. Garg, K. Gargiulo, C. and Garibli, A. Garner, K. Gasik, P. Gauger, E. F. Gautam, A. Ducati, M. B. Gay Germain, M. Ghosh, P. Ghosh, S. K. and Giacalone, M. Gianotti, P. Giubellino, P. Giubilato, P. and Glaenzer, A. M. C. Glaessel, P. Goh, D. J. Q. Gonzalez, V Gonzalez-Trueba, L. H. Gorbunov, S. Gorgon, M. and Gorlich, L. Gotovac, S. Grabski, V Graczykowski, L. K. and Greiner, L. Grelli, A. Grigoras, C. Grigoriev, V and Grigoryan, S. Grosa, F. Grosse-Oetringhaus, J. F. Grosso, R. and Guardiano, G. G. Guernane, R. Guilbaud, M. Gulbrandsen, K. Gunji, T. Guo, W. Gupta, A. Gupta, R. Guzman, S. P. Gyulai, L. Habib, M. K. Hadjidakis, C. Hamagaki, H. and Hamid, M. Hannigan, R. Haque, M. R. Harlenderova, A. and Harris, J. W. Harton, A. Hasenbichler, J. A. Hassan, H. and Hatzifotiadou, D. Hauer, P. Havener, L. B. Heckel, S. T. and Hellbar, E. Helstrup, H. Herman, T. Hernandez, E. G. and Corral, G. Herrera Herrmann, F. Hetland, K. F. Hillemanns, H. Hills, C. Hippolyte, B. Hofman, B. Hohlweger, B. and Honermann, J. Hong, G. H. Horak, D. Hornung, S. Horzyk, A. Hosokawa, R. Hou, Y. Hristov, P. Hughes, C. Huhn, P. Huhta, L. M. Hulse, V, C. Humanic, T. J. Hushnud, H. and Husova, L. A. Hutson, A. Iddon, J. P. Ilkaev, R. and Ilyas, H. Inaba, M. Innocenti, G. M. Ippolitov, M. and Isakov, A. Isidori, T. Islam, M. S. Ivanov, M. Ivanov, V and Izucheev, V Jablonski, M. Jacak, B. Jacazio, N. and Jacobs, P. M. Jadlovska, S. Jadlovsky, J. Jaelani, S. and Jahnke, C. Jakubowska, M. J. Jalotra, A. Janik, M. A. and Janson, T. Jercic, M. Jevons, O. Jimenez, A. A. P. and Jonas, F. Jones, P. G. Jowett, J. M. Jung, J. Jung, M. and Junique, A. Jusko, A. Kaewjai, J. Kalinak, P. and Kalteyer, A. S. Kalweit, A. Kaplin, V Uysal, A. Karasu and Karatovic, D. Karavichev, O. Karavicheva, T. Karczmarczyk, P. Karpechev, E. Kashyap, V Kazantsev, A. Kebschull, U. and Keidel, R. Keijdener, D. L. D. Keil, M. Ketzer, B. and Khabanova, Z. Khan, A. M. Khan, S. Khanzadeev, A. and Kharlov, Y. Khatun, A. Khuntia, A. Kileng, B. Kim, B. and Kim, C. Kim, D. J. Kim, E. J. Kim, J. Kim, J. S. and Kim, J. Kim, J. Kim, M. Kim, S. Kim, T. Kirsch, S. and Kisel, I Kiselev, S. Kisiel, A. Kitowski, J. P. and Klay, J. L. Klein, J. Klein, S. Klein-Bosing, C. and Kleiner, M. Klemenz, T. Kluge, A. Knospe, A. G. Kobdaj, C. Koehler, M. K. Kollegger, T. Kondratyev, A. and Kondratyeva, N. Kondratyuk, E. Konig, J. Konigstorfer, S. A. and Konopka, P. J. Kornakov, G. Koryciak, S. D. Kotliarov, A. Kovalenko, O. Kovalenko, V Kowalski, M. Kralik, I and Kreis, L. Krivda, M. Krizek, F. Gajdosova, K. Krizkova and Kroesen, M. Krueger, M. Kryshen, E. Krzewicki, M. Kuhn, C. Kuijer, P. G. Kumaoka, T. Kumar, D. Kumar, L. and Kumar, N. Kundu, S. Kurashvili, P. Kurepin, A. Kurepin, A. B. Kuryakin, A. Kushpil, S. Kvapil, J. Kweon, M. J. and Kwon, J. Y. Kwon, Y. LaPointe, S. L. La Rocca, P. and Lai, Y. S. Lakrathok, A. Lamanna, M. Langoy, R. Lapidus, K. Larionov, P. Laudi, E. Lautner, L. Lavicka, R. and Lazareva, T. Lea, R. Lehrbach, J. Lemmon, R. C. Leon Monzon, I Lesser, E. D. Lettrich, M. Levai, P. Li, X. and Li, X. L. Lien, J. Lietava, R. Lim, B. Lim, S. H. and Lindenstruth, V Lindner, A. Lippmann, C. Liu, A. and Liu, D. H. Liu, J. Lofnes, I. M. Loginov, V Loizides, C. and Loncar, P. Lopez, J. A. Lopez, X. Lopez Torres, E. and Luhder, J. R. Lunardon, M. Luparello, G. Ma, Y. G. and Maevskaya, A. Mager, M. Mahmoud, T. Maire, A. Malaev, M. and Malik, N. M. Malik, Q. W. Malik, S. K. Malinina, L. and Mal'Kevich, D. Mallick, D. Mallick, N. Mandaglio, G. and Manko, V Manso, F. Manzari, V Mao, Y. Margagliotti, V, G. Margotti, A. Marin, A. Markert, C. Marquard, M. and Martin, N. A. Martinengo, P. Martinez, J. L. Martinez, I, M. and Garcia, G. Martinez Masciocchi, S. Masera, M. Masoni, A. and Massacrier, L. Mastroserio, A. Mathis, A. M. Matonoha, O. Matuoka, P. F. T. Matyja, A. Mayer, C. Mazuecos, A. L. Mazzaschi, F. Mazzilli, M. Mazzoni, M. A. Mdhluli, J. E. Mechler, A. F. Melikyan, Y. Menchaca-Rocha, A. and Meninno, E. Menon, A. S. Meres, M. Mhlanga, S. Miake, Y. and Micheletti, L. Migliorin, L. C. Mihaylov, D. L. and Mikhaylov, K. Mishra, A. N. Modak, A. Mohanty, A. P. and Mohanty, B. Khan, M. Mohisin Molander, M. A. Moravcova, Z. and Mordasini, C. De Godoy, D. A. Moreira Morozov, I Morsch, A. Mrnjavac, T. Muccifora, V Mudnic, E. Muehlheim, D. and Muhuri, S. Mulligan, J. D. Mulliri, A. Munhoz, M. G. and Munzer, R. H. Murakami, H. Murray, S. Musa, L. Musinsky, J. Myrcha, J. W. Naik, B. Nair, R. Nandi, B. K. and Nania, R. Nappi, E. Nassirpour, A. F. Nath, A. Nattrass, C. Neagu, A. Nellen, L. Nesbo, V, S. Neskovic, G. and Nesterov, D. Nielsen, B. S. Nikolaev, S. Nikulin, S. and Nikulin, V Noferini, F. Noh, S. Nomokonov, P. Norman, J. and Novitzky, N. Nowakowski, P. Nyanin, A. Nystrand, J. and Ogino, M. Ohlson, A. Okorokov, V. A. Oleniacz, J. and DaSilva, A. C. Oliveira Oliver, M. H. Onnerstad, A. and Oppedisano, C. Ortiz Velasquez, A. Osako, T. Oskarsson, A. and Otwinowski, J. Oya, M. Oyama, K. Pachmayer, Y. and Padhan, S. Pagano, D. Palasciano, A. Pan, J. Panebianco, S. Park, J. Parkkila, J. E. Pathak, S. P. Patra, R. N. and Paul, B. Pei, H. Peitzmann, T. Peng, X. Pereira, L. G. Da Costa, H. Pereira Peresunko, D. Perez, G. M. and Perrin, S. Pestov, Y. Petrovici, M. Pezzi, R. P. Piano, S. Pikna, M. Pillot, P. Pinazza, O. Pinsky, L. and Pinto, C. Pisano, S. Planinic, M. Pliquett, F. and Poghosyan, M. G. Polichtchouk, B. Politano, S. Poljak, N. and Pop, A. Porteboeuf-Houssais, S. Porter, J. Pozdniakov, V and Prasad, S. K. Preghenella, R. Prino, F. Pruneau, C. A. and Pshenichnov, I Puccio, M. Qiu, S. Quaglia, L. and Quishpe, R. E. Ragoni, S. Rakotozafindrabe, A. Ramello, L. and Rami, F. Ramirez, S. A. R. Ramos, A. G. T. Rancien, T. A. Raniwala, R. Raniwala, S. Rasanen, S. S. Rath, R. and Ravasenga, I Read, K. F. Redelbach, A. R. Redlich, K. and Rehman, A. Reichelt, P. Reidt, F. Reme-ness, H. A. and Rescakova, Z. Reygers, K. Riabov, A. Riabov, V Richert, T. Richter, M. Riegler, W. Riggi, F. Ristea, C. and Cahuantzi, M. Rodriguez Roed, K. Rogalev, R. Rogochaya, E. and Rogoschinski, T. S. Rohr, D. Roehrich, D. Rojas, P. F. and Rokita, P. S. Ronchetti, F. Rosano, A. Rosas, E. D. and Rossi, A. Roy, A. Roy, P. Roy, S. Rubini, N. Rueda, V, O. Ruggiano, D. Rui, R. Rumyantsev, B. Russek, P. G. and Russo, R. Rustamov, A. Ryabinkin, E. Ryabov, Y. and Rybicki, A. Rytkonen, H. Rzesa, W. Saarimaki, O. A. M. and Sadek, R. Sadovsky, S. Saetre, J. Saha, S. K. Saha, S. and Sahoo, B. Sahoo, P. Sahoo, R. Sahoo, S. Sahu, D. and Sahu, P. K. Saini, J. Sakai, S. Salvan, M. P. Sambyal, S. Samsonov, V Sarkar, D. Sarkar, N. Sarma, P. and Sarti, V. M. Sas, M. H. P. Schambach, J. Scheid, H. S. and Schiaua, C. Schicker, R. Schmah, A. Schmidt, C. Schmidt, H. R. Schmidt, M. O. Schmidt, M. Schmidt, V, N. Schmier, A. R. Schotter, R. Schukraft, J. Schwarz, K. Schweda, K. and Scioli, G. Scomparin, E. Seger, J. E. Sekiguchi, Y. and Sekihata, D. Selyuzhenkov, I Senyukov, S. Seo, J. J. and Serebryakov, D. Sevcenco, A. Shaba, T. J. Shabanov, A. and Shabetai, A. Shahoyan, R. Shaikh, W. Shangaraev, A. and Sharma, A. Sharma, H. Sharma, M. Sharma, N. Sharma, S. and Sharma, U. Sheibani, O. Shigaki, K. Shimomura, M. and Shirinkin, S. Shou, Q. Sibiriak, Y. Siddhanta, S. and Siemiarczuk, T. Silva, T. F. Silvermyr, D. Simantathammakul, T. Simonetti, G. Singh, B. Singh, R. Singh, R. and Singh, R. Singh, V. K. Singhal, V Sinha, T. Sitar, B. and Sitta, M. Skaali, T. B. Skorodumovs, G. Slupecki, M. and Smirnov, N. Snellings, R. J. M. Soncco, C. Song, J. and Songmoolnak, A. Soramel, F. Sorensen, S. Sputowska, I and Stachel, J. Stan, I Steffanic, P. J. Stiefelmaier, S. F. and Stocco, D. Storehaug, I Storetvedt, M. M. Stratmann, P. and Stylianidis, C. P. Suaide, A. A. P. Suire, C. Sukhanov, M. and Suljic, M. Sultanov, R. Sumberia, V Sumowidagdo, S. and Swain, S. Szabo, A. Szarka, I Tabassam, U. Taghavi, S. F. Taillepied, G. Takahashi, J. Tambave, G. J. Tang, S. and Tang, Z. Takaki, J. D. Tapia Tarhini, M. Tarzila, M. G. and Tauro, A. Tejeda Munoz, G. Telesca, A. Terlizzi, L. and Terrevoli, C. Tersimonov, G. Thakur, S. Thomas, D. and Tieulent, R. Tikhonov, A. Timmins, A. R. Tkacik, M. and Toia, A. Topilskaya, N. Toppi, M. Torales-Acosta, F. and Tork, T. Torres, S. R. Trifiro, A. Tripathy, S. and Tripathy, T. Trogolo, S. Trubnikov, V Trzaska, W. H. and Trzcinski, T. P. Tumkin, A. Turrisi, R. Tveter, T. S. and Ullaland, K. Uras, A. Urioni, M. Usai, G. L. Vala, M. and Valle, N. Vallero, S. van Doremalen, L. V. R. van Leeuwen, M. VandeVyvre, P. Varga, D. Varga, Z. and Varga-Kofarago, M. Vasileiou, M. Vasiliev, A. Doce, O. Vazquez Vechernin, V. Vercellin, E. Limon, S. Vergara and Vermunt, L. Vertesi, R. Verweij, M. Vickovic, L. and Vilakazi, Z. Baillie, O. Villalobos Vino, G. Vinogradov, A. and Virgili, T. Vislavicius, V. Vodopyanov, A. Volkel, B. and Volkl, M. A. Voloshin, K. Voloshin, S. A. Volpe, G. and von Haller, B. Vorobyev, I Voscek, D. Vozniuk, N. and Vrlakova, J. Wagner, B. Wang, C. Wang, D. Weber, M. and Weelden, V, R. J. G. Wegrzynek, A. Wenzel, S. C. Wessels, J. P. Wiechula, J. Wikne, J. Wilk, G. Wilkinson, J. and Willems, G. A. Windelband, B. Winn, M. Witt, W. E. and Wright, J. R. Wu, W. Wu, Y. Xu, R. Yadav, A. K. and Yalcin, S. Yamaguchi, Y. Yamakawa, K. Yang, S. Yano, S. and Yin, Z. Yoo, I-K Yoon, J. H. Yuan, S. Yuncu, A. and Zaccolo, V Zampolli, C. Zanoli, H. J. C. Zardoshti, N. and Zarochentsev, A. Zavada, P. Zaviyalov, N. Zhalov, M. and Zhang, B. Zhang, S. Zhang, X. Zhang, Y. Zherebchevskii, V Zhi, Y. Zhigareva, N. Zhou, D. Zhou, Y. Zhu, J. and Zhu, Y. Zinovjev, G. Zurlo, N. ALICE Collaboration
- Subjects
Nuclear Theory ,High Energy Physics::Phenomenology ,High Energy Physics::Experiment ,Nuclear Experiment - Abstract
The production of prompt D-0, D+, and D*(+) mesons was measured at midrapidity (vertical bar y vertical bar < 0.5) in Pb-Pb collisions at the centre-of-mass energy per nucleon-nucleon pair root S-NN = 5.02 TeV with the ALICE detector at the LHC. The D mesons were reconstructed via their hadronic decay channels and their production yields were measured in central (0-10%) and semicentral (30-50%) collisions. The measurement was performed up to a transverse momentum (p(T)) of 36 or 50 GeV/c depending on the D meson species and the centrality interval. For the first time in Pb-Pb collisions at the LHC, the yield of D-0 mesons was measured down to p(T) = 0, which allowed a model-independent determination of the p(T)-integrated yield per unit of rapidity (dN/dy). A maximum suppression by a factor 5 and 2.5 was observed with the nuclear modification factor (R-AA) of prompt D mesons at p(T) = 6-8 GeV/c for the 0-10% and 30-50% centrality classes, respectively. The D-meson R-AA is compared with that of charged pions, charged hadrons, and J/psi mesons as well as with theoretical predictions. The analysis of the agreement between the measured R-AA, elliptic (v(2)) and triangular (v(3)) flow, and the model predictions allowed us to constrain the charm spatial diffusion coefficient D-s. Furthermore the comparison of R-AA and v(2) with different implementations of the same models provides an important insight into the role of radiative energy loss as well as charm quark recombination in the hadronisation mechanisms.
- Published
- 2022
8. Charm-quark fragmentation fractions and production cross section at mid rapidity in pp collisions at the LHC
- Author
-
Acharya, S. Adamova, D. Adler, A. Adolfsson, J. Rinella, G. Aglieri Agnello, M. Agrawal, N. Ahammed, Z. Ahmad, S. and Ahn, S. U. Ahuja, I Akbar, Z. Akindinov, A. and Al-Turany, M. Alam, S. N. Aleksandrov, D. Alessandro, B. and Alfanda, H. M. Alfaro Molina, R. Ali, B. Ali, Y. Alici, A. Alizadehvandchali, N. Alkin, A. Alme, J. Alt, T. and Altenkamper, L. Altsybeev, I Anaam, M. N. Andrei, C. and Andreou, D. Andronic, A. Angeletti, M. Anguelov, V and Antinori, F. Antonioli, P. Anuj, C. Apadula, N. and Aphecetche, L. Appelshaeuser, H. Arcelli, S. Arnaldi, R. and Arsene, I. C. Arslandok, M. Augustinus, A. Averbeck, R. and Aziz, S. Azmi, M. D. Badala, A. Baek, Y. W. Bai, X. and Bailhache, R. Bailung, Y. Bala, R. Balbino, A. and Baldisseri, A. Balis, B. Ball, M. Banerjee, D. Barbera, R. Barioglio, L. Barlou, M. Barnafoldi, G. G. Barnby, L. S. Barret, V Bartels, C. Barth, K. Bartsch, E. and Baruffaldi, F. Bastid, N. Basu, S. Batigne, G. Batyunya, B. Bauri, D. Alba, J. L. Bazo Bearden, I. G. Beattie, C. and Belikov, I Hechavarria, A. D. C. Bell Bellini, F. and Bellwied, R. Belokurova, S. Belyaev, V Bencedi, G. and Beole, S. Bercuci, A. Berdnikov, Y. Berdnikova, A. and Berenyi, D. Bergmann, L. Besoiu, M. G. Betev, L. and Bhaduri, P. P. Bhasin, A. Bhat, M. A. Bhattacharjee, B. and Bhattacharya, P. Bianchi, L. Bianchi, N. Biernat, J. and Bilandzic, A. Biro, G. Biswas, S. Blair, J. T. Blau, D. and Blidaru, M. B. Blume, C. Boca, G. Bock, F. Bogdanov, A. Boi, S. Bok, J. Boldizsar, L. Bolozdynya, A. and Bombara, M. Bond, P. M. Bonomi, G. Borel, H. Borissov, A. Bossi, H. Botta, E. Bratrud, L. Braun-Munzinger, P. and Bregant, M. Broz, M. Bruno, G. E. Buckland, M. D. and Budnikov, D. Buesching, H. Bufalino, S. Bugnon, O. and Buhler, P. Buthelezi, Z. Butt, J. B. Bysiak, S. A. and Caffarri, D. Cai, M. Caines, H. Caliva, A. Calvo Villar, E. Camacho, J. M. M. Camacho, R. S. Camerini, P. Canedo, F. D. M. Carnesecchi, F. Caron, R. Castellanos, J. Castillo and Casula, E. A. R. Catalano, F. Sanchez, C. Ceballos and Chakraborty, P. Chandra, S. Chapeland, S. Chartier, M. and Chattopadhyay, S. Chattopadhyay, S. Chauvin, A. Chavez, T. G. Cheshkov, C. Cheynis, B. Barroso, V. Chibante and Chinellato, D. D. Cho, S. Chochula, P. Christakoglou, P. and Christensen, C. H. Christiansen, P. Chujo, T. Cicalo, C. and Cifarelli, L. Cindolo, F. Ciupek, M. R. Clai, G. and Cleymans, J. Colamaria, F. Colburn, J. S. Colella, D. and Collu, A. Colocci, M. Concas, M. Balbastre, G. Conesa and del Valle, Z. Conesa Contin, G. Contreras, J. G. Coquet, M. L. Cormier, T. M. Cortese, P. Cosentino, M. R. Costa, F. and Costanza, S. Crochet, P. Cuautle, E. Cui, P. and Cunqueiro, L. Dainese, A. Damas, F. P. A. Danisch, M. C. and Danu, A. Das, I Das, P. Das, P. Das, S. Dash, S. and De, S. De Caro, A. de Cataldo, G. De Cilladi, L. de Cuveland, J. De Falco, A. De Gruttola, D. De Marco, N. and De Martin, C. De Pasquale, S. Deb, S. Degenhardt, H. F. and Deja, K. R. Dello Stritto, L. Delsanto, S. Deng, W. and Dhankher, P. Di Bari, D. Di Mauro, A. Diaz, R. A. and Dietel, T. Ding, Y. Divia, R. Djuvsland, O. Dixit, D. U. and Dmitrieva, U. Do, J. Dobrin, A. Donigus, B. Dordic, O. Dubey, A. K. Dubla, A. Dudi, S. Dukhishyam, M. and Dupieux, P. Dzalaiova, N. Eder, T. M. Ehlers, R. J. and Eikeland, V. N. Elia, D. Erazmus, B. Ercolessi, F. and Erhardt, F. Erokhin, A. Ersdal, M. R. Espagnon, B. and Eulisse, G. Evans, D. Evdokimov, S. Fabbietti, L. and Faggin, M. Faivre, J. Fan, F. Fantoni, A. Fasel, M. and Fecchio, P. Feliciello, A. Feofilov, G. Fernandez Tellez, A. and Ferrero, A. Ferretti, A. Feuillard, V. J. G. Figiel, J. and Filchagin, S. Finogeev, D. Fionda, F. M. Fiorenza, G. and Flor, F. Flores, A. N. Foertsch, S. Foka, P. Fokin, S. Fragiacomo, E. Frajna, E. Fuchs, U. Funicello, N. and Furget, C. Furs, A. Gaardhoje, J. J. Gagliardi, M. Gago, A. M. Gal, A. Galvan, C. D. Ganoti, P. Garabatos, C. and Garcia, J. R. A. Garcia-Solis, E. Garg, K. Gargiulo, C. and Garibli, A. Garner, K. Gasik, P. Gauger, E. F. Gautam, A. Ducati, M. B. Gay Germain, M. Ghosh, J. Ghosh, P. and Ghosh, S. K. Giacalone, M. Gianotti, P. Giubellino, P. and Giubilato, P. Glaenzer, A. M. C. Glassel, P. Goh, D. J. Q. and Gonzalez, V Gonzalez-Trueba, L. H. Gorbunov, S. Gorgon, M. Gorlich, L. Gotovac, S. Grabski, V Graczykowski, L. K. Greiner, L. Grelli, A. Grigoras, C. Grigoriev, V and Grigoryan, A. Grigoryan, S. Groettvik, O. S. Grosa, F. and Grosse-Oetringhaus, J. F. Grosso, R. Guardiano, G. G. and Guernane, R. Guilbaud, M. Gulbrandsen, K. Gunji, T. and Gupta, A. Gupta, R. Guzman, S. P. Gyulai, L. Habib, M. K. Hadjidakis, C. Halimoglu, G. Hamagaki, H. Hamar, G. and Hamid, M. Hannigan, R. Haque, M. R. Harlenderova, A. and Harris, J. W. Harton, A. Hasenbichler, J. A. Hassan, H. and Hatzifotiadou, D. Hauer, P. Havener, L. B. Hayashi, S. and Heckel, S. T. Hellbar, E. Helstrup, H. Herman, T. and Hernandez, E. G. Herrera Corral, G. Herrmann, F. Hetland, K. F. Hillemanns, H. Hills, C. Hippolyte, B. Hofman, B. and Hohlweger, B. Honermann, J. Hong, G. H. Horak, D. and Hornung, S. Horzyk, A. Hosokawa, R. Hristov, P. Huang, C. Hughes, C. Huhn, P. Humanic, T. J. Hushnud, H. and Husova, L. A. Hutson, A. Hutter, D. Iddon, J. P. Ilkaev, R. Ilyas, H. Inaba, M. Innocenti, G. M. Ippolitov, M. and Isakov, A. Islam, M. S. Ivanov, M. Ivanov, V and Izucheev, V Jablonski, M. Jacak, B. Jacazio, N. Jacobs, P. M. Jadlovska, S. Jadlovsky, J. Jaelani, S. Jahnke, C. and Jakubowska, M. J. Jalotra, A. Janik, M. A. Janson, T. and Jercic, M. Jevons, O. Jonas, F. Jones, P. G. Jowett, J. M. Jung, J. Jung, M. Junique, A. Jusko, A. and Kaewjai, J. Kalinak, P. Kalweit, A. Kaplin, V Kar, S. and Uysal, A. Karasu Karatovic, D. Karavichev, O. and Karavicheva, T. Karczmarczyk, P. Karpechev, E. Kazantsev, A. and Kebschull, U. Keidel, R. Keijdener, D. L. D. Keil, M. and Ketzer, B. Khabanova, Z. Khan, A. M. Khan, S. and Khanzadeev, A. Kharlov, Y. Khatun, A. Khuntia, A. and Kileng, B. Kim, B. Kim, C. Kim, D. Kim, D. J. Kim, E. J. Kim, J. Kim, J. S. Kim, J. Kim, J. Kim, J. and Kim, M. Kim, S. Kim, T. Kirsch, S. Kisel, I Kiselev, S. Kisiel, A. Kitowski, J. P. Klay, J. L. Klein, J. and Klein, S. Klein-Bosing, C. Kleiner, M. Klemenz, T. and Kluge, A. Knospe, A. G. Kobdaj, C. Kohler, M. K. and Kollegger, T. Kondratyev, A. Kondratyeva, N. Kondratyuk, E. and Konig, J. Konigstorfer, S. A. Konopka, P. J. Kornakov, G. Koryciak, S. D. Koska, L. Kotliarov, A. Kovalenko, O. and Kovalenko, V Kowalski, M. Kralik, I Kreis, L. and Krivda, M. Krizek, F. Gajdosova, K. Krizkova Kroesen, M. and Kruger, M. Kryshen, E. Krzewicki, M. Kuhn, C. Kuijer, P. G. Kumaoka, T. Kumar, D. Kumar, L. Kumar, N. Kundu, S. Kurashvili, P. Kurepin, A. Kurepin, A. B. Kuryakin, A. Kushpil, S. Kvapil, J. Kweon, M. J. Kwon, J. Y. and Kwon, Y. La Pointe, S. L. La Rocca, P. Lai, Y. S. and Lakrathok, A. Lamanna, M. Langoy, R. Lapidus, K. and Larionov, P. Laudi, E. Lautner, L. Lavicka, R. Lazareva, T. Lea, R. Lehrbach, J. Lemmon, R. C. Monzon, I. Leon and Lesser, E. D. Lettrich, M. Levai, P. Li, X. Li, X. L. Lien, J. Lietava, R. Lim, B. Lim, S. H. and Lindenstruth, V Lindner, A. Lippmann, C. Liu, A. Liu, J. and Lofnes, I. M. Loginov, V Loizides, C. Loncar, P. and Lopez, J. A. Lopez, X. Lopez Torres, E. Luhder, J. R. and Lunardon, M. Luparello, G. Ma, Y. G. Maevskaya, A. and Mager, M. Mahmoud, T. Maire, A. Malaev, M. Malik, N. M. and Malik, Q. W. Malinina, L. Mal'Kevich, D. Mallick, N. and Malzacher, P. Mandaglio, G. Manko, V Manso, F. Manzari, V Mao, Y. Mares, J. Margagliotti, V, G. Margotti, A. and Marin, A. Markert, C. Marquard, M. Martin, N. A. and Martinengo, P. Martinez, J. L. Martinez, I, M. Garcia, G. Martinez Masciocchi, S. Masera, M. Masoni, A. and Massacrier, L. Mastroserio, A. Mathis, A. M. Matonoha, O. and Matuoka, P. F. T. Matyja, A. Mayer, C. Mazuecos, A. L. and Mazzaschi, F. Mazzilli, M. Mazzoni, M. A. Mdhluli, J. E. and Mechler, A. F. Meddi, F. Melikyan, Y. Menchaca-Rocha, A. and Meninno, E. Menon, A. S. Meres, M. Mhlanga, S. and Miake, Y. Micheletti, L. Migliorin, L. C. Mihaylov, D. L. and Mikhaylov, K. Mishra, A. N. Modak, A. Mohanty, A. P. and Mohanty, B. Khan, M. Mohisin Moravcova, Z. Mordasini, C. and De Godoy, D. A. Moreira Moreno, L. A. P. Morozov, I Morsch, A. Mrnjavac, T. Muccifora, V Mudnic, E. Muhlheim, D. and Muhuri, S. Mulligan, J. D. Mulliri, A. Munhoz, M. G. and Munzer, R. H. Murakami, H. Murray, S. Musa, L. Musinsky, J. Myrcha, J. W. Naik, B. Nair, R. Nandi, B. K. and Nania, R. Nappi, E. Naru, M. U. Nassirpour, A. F. Nath, A. Nattrass, C. Neagu, A. Nellen, L. Nesbo, V, S. and Neskovic, G. Nesterov, D. Nielsen, B. S. Nikolaev, S. and Nikulin, S. Nikulin, V Noferini, F. Noh, S. Nomokonov, P. Norman, J. Novitzky, N. Nowakowski, P. Nyanin, A. and Nystrand, J. Ogino, M. Ohlson, A. Okorokov, V. A. and Oleniacz, J. Da Silva, A. C. Oliveira Oliver, M. H. and Onnerstad, A. Oppedisano, C. Velasquez, A. Ortiz Osako, T. and Oskarsson, A. Otwinowski, J. Oyama, K. Pachmayer, Y. and Padhan, S. Pagano, D. Palasciano, A. Pan, J. Panebianco, S. Pareek, P. Park, J. Parkkila, J. E. Pathak, S. P. and Patra, R. N. Paul, B. Pazzini, J. Pei, H. Peitzmann, T. and Peng, X. Pereira, L. G. Da Costa, H. Pereira Peresunko, D. Perez, G. M. Perrin, S. Pestov, Y. Petrovici, M. and Pezzi, R. P. Piano, S. Pikna, M. Pillot, P. Pinazza, O. and Pinsky, L. Pinto, C. Pisano, S. Planinic, M. and Pliquett, F. Poghosyan, M. G. Polichtchouk, B. Politano, S. and Poljak, N. Pop, A. Porteboeuf-Houssais, S. Porter, J. and Pozdniakov, V Prasad, S. K. Preghenella, R. Prino, F. and Pruneau, C. A. Pshenichnov, I Puccio, M. Qiu, S. and Quaglia, L. Quishpe, R. E. Ragoni, S. Rakotozafindrabe, A. and Ramello, L. Rami, F. Ramirez, S. A. R. Ramos, A. G. T. and Rancien, T. A. Raniwala, R. Raniwala, S. Rasanen, S. S. and Rath, R. Ravasenga, I Read, K. F. Redelbach, A. R. and Redlich, K. Rehman, A. Reichelt, P. Reidt, F. Reme-ness, H. A. Renfordt, R. Rescakova, Z. Reygers, K. Riabov, A. and Riabov, V Richert, T. Richter, M. Riegler, W. Riggi, F. Ristea, C. Rode, S. P. Rodriguez Cahuantzi, M. Roed, K. Rogalev, R. Rogochaya, E. Rogoschinski, T. S. Rohr, D. Rohrich, D. Rojas, P. F. Rokita, P. S. Ronchetti, F. and Rosano, A. Rosas, E. D. Rossi, A. Rotondi, A. Roy, A. Roy, P. Roy, S. Rubini, N. Rueda, V, O. Rui, R. and Rumyantsev, B. Russek, P. G. Rustamov, A. Ryabinkin, E. and Ryabov, Y. Rybicki, A. Rytkonen, H. Rzesa, W. and Saarimaki, O. A. M. Sadek, R. Sadovsky, S. Saetre, J. and Saha, S. K. Saha, S. Sahoo, B. Sahoo, P. Sahoo, R. and Sahoo, S. Sahu, D. Sahu, P. K. Saini, J. Sakai, S. and Sambyal, S. Samsonov, V Sarkar, D. Sarkar, N. Sarma, P. and Sarti, V. M. Sas, M. H. P. Schambach, J. Scheid, H. S. and Schiaua, C. Schicker, R. Schmah, A. Schmidt, C. and Schmidt, H. R. Schmidt, M. O. Schmidt, M. Schmidt, V, N. and Schmier, A. R. Schotter, R. Schukraft, J. Schutz, Y. and Schwarz, K. Schweda, K. Scioli, G. Scomparin, E. Seger, J. E. Sekiguchi, Y. Sekihata, D. Selyuzhenkov, I and Senyukov, S. Seo, J. J. Serebryakov, D. Sevcenco, A. and Shaba, T. J. Shabanov, A. Shabetai, A. Shahoyan, R. and Shaikh, W. Shangaraev, A. Sharma, A. Sharma, H. Sharma, M. Sharma, N. Sharma, S. Sharma, U. Sheibani, O. and Shigaki, K. Shimomura, M. Shirinkin, S. Shou, Q. and Sibiriak, Y. Siddhanta, S. Siemiarczuk, T. Silva, T. F. and Silvermyr, D. Simonetti, G. Singh, B. Singh, R. Singh, R. Singh, R. Singh, V. K. Singhal, V Sinha, T. and Sitar, B. Sitta, M. Skaali, T. B. Skorodumovs, G. and Slupecki, M. Smirnov, N. Snellings, R. J. M. Soncco, C. and Song, J. Songmoolnak, A. Soramel, F. Sorensen, S. and Sputowska, I Stachel, J. Stan, I Steffanic, P. J. and Stiefelmaier, S. F. Stocco, D. Storehaug, I Storetvedt, M. M. Stylianidis, C. P. Suaide, A. A. P. Sugitate, T. and Suire, C. Suljic, M. Sultanov, R. Sumbera, M. Sumberia, V Sumowidagdo, S. Swain, S. Szabo, A. Szarka, I and Tabassam, U. Taghavi, S. F. Taillepied, G. Takahashi, J. and Tambave, G. J. Tang, S. Tang, Z. Tarhini, M. Tarzila, M. G. Tauro, A. Tejeda Munoz, G. Telesca, A. Terlizzi, L. and Terrevoli, C. Tersimonov, G. Thakur, S. Thomas, D. and Tieulent, R. Tikhonov, A. Timmins, A. R. Tkacik, M. and Toia, A. Topilskaya, N. Toppi, M. Torales-Acosta, F. and Tork, T. Torres, R. C. Torres, S. R. Trifiro, A. and Tripathy, S. Tripathy, T. Trogolo, S. Trombetta, G. and Trubnikov, V Trzaska, W. H. Trzcinski, T. P. Trzeciak, B. A. and Tumkin, A. Turrisi, R. Tveter, T. S. Ullaland, K. and Uras, A. Urioni, M. Usai, G. L. Vala, M. Valle, N. and Vallero, S. van der Kolk, N. van Doremalen, L. V. R. van Leeuwen, M. Vande Vyvre, P. Varga, D. Varga, Z. and Varga-Kofarago, M. Vargas, A. Vasileiou, M. Vasiliev, A. and Doce, O. Vazquez Vechernin, V. Vercellin, E. Vergara Limon, S. Vermunt, L. Vertesi, R. Verweij, M. Vickovic, L. and Vilakazi, Z. Baillie, O. Villalobos Vino, G. Vinogradov, A. and Virgili, T. Vislavicius, V. Vodopyanov, A. Volkel, B. and Volkl, M. A. Voloshin, K. Voloshin, S. A. Volpe, G. and von Haller, B. Vorobyev, I Voscek, D. Vozniuk, N. and Vrlakova, J. Wagner, B. Wang, C. Wang, D. Weber, M. and Weelden, V, R. J. G. Wegrzynek, A. Wenzel, S. C. Wessels, J. P. Wiechula, J. Wikne, J. Wilk, G. Wilkinson, J. and Willems, G. A. Windelband, B. Winn, M. Witt, W. E. and Wright, J. R. Wu, W. Wu, Y. Xu, R. Yalcin, S. and Yamaguchi, Y. Yamakawa, K. Yang, S. Yano, S. Yin, Z. and Yokoyama, H. Yoo, I-K Yoon, J. H. Yuan, S. Yuncu, A. and Zaccolo, V Zaman, A. Zampolli, C. Zanoli, H. J. C. and Zardoshti, N. Zarochentsev, A. Zavada, P. Zaviyalov, N. and Zbroszczyk, H. Zhalov, M. Zhang, S. Zhang, X. Zhang, Y. and Zherebchevskii, V Zhi, Y. Zhou, D. Zhou, Y. Zhu, J. and Zhu, Y. Zichichi, A. Zinovjev, G. Zurlo, N. ALICE Collaboration
- Subjects
High Energy Physics::Phenomenology ,High Energy Physics::Experiment ,Nuclear Experiment - Abstract
Recent p(T)-integrated cross-section measurements of the ground-state charm mesons and baryons, D-0, D+, D-s(+), Lambda(+)(c), and Xi(0)(c) are used to evaluate the charm fragmentation fractions and production cross section per unit of rapidity at midrapidity (vertical bar y vertical bar < 0.5), in pp collisions at root s = 5.02 TeV at the LHC. The latter is d sigma(c)/dy vertical bar(vertical bar y vertical bar
- Published
- 2022
9. Non-oncogene dependencies: Novel opportunities for cancer therapy.
- Author
-
Di Marco T, Mazzoni M, Greco A, and Cassinelli G
- Subjects
- Humans, Animals, Oncogenes genetics, Oncogene Addiction genetics, Molecular Targeted Therapy methods, Molecular Targeted Therapy trends, Tumor Microenvironment drug effects, Tumor Microenvironment physiology, Neoplasms drug therapy, Neoplasms genetics, Neoplasms metabolism, Antineoplastic Agents therapeutic use, Antineoplastic Agents pharmacology
- Abstract
Targeting oncogene addictions have changed the history of subsets of malignancies and continues to represent an excellent therapeutic opportunity. Nonetheless, alternative strategies are required to treat malignancies driven by undruggable oncogenes or loss of tumor suppressor genes and to overcome drug resistance also occurring in cancers addicted to actionable drivers. The discovery of non-oncogene addiction (NOA) uncovered novel therapeutically exploitable "Achilles' heels". NOA refers to genes/pathways not oncogenic per sé but essential for the tumor cell growth/survival while dispensable for normal cells. The clinical success of several classes of conventional and molecular targeted agents can be ascribed to their impact on both tumor cell-associated intrinsic as well as microenvironment-related extrinsic NOA. The integration of genetic, computational and pharmacological high-throughput approaches led to the identification of an expanded repertoire of synthetic lethality interactions implicating NOA targets. Only a few of them have been translated into the clinics as most NOA vulnerabilities are not easily druggable or appealing targets. Nonetheless, their identification has provided in-depth knowledge of tumor pathobiology and suggested novel therapeutic opportunities. Here, we summarize conceptual framework of intrinsic and extrinsic NOA providing exploitable vulnerabilities. Conventional and emerging methodological approaches used to disclose NOA dependencies are reported together with their limits. We illustrate NOA paradigmatic and peculiar examples and outline the functional/mechanistic aspects, potential druggability and translational interest. Finally, we comment on difficulties in exploiting the NOA-generated knowledge to develop novel therapeutic approaches to be translated into the clinics and to fully harness the potential of clinically available drugs., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
10. Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region.
- Author
-
Giovenale AMG, Turco EM, Mazzoni M, Ferrone I, Torres B, Bernardini L, Vulcano E, Ferrari D, Onesimo R, D'Arrigo S, Zampino G, Pennuto M, De Luca A, Vescovi AL, and Rosati J
- Abstract
Smith-Magenis syndrome (SMS) is a complex neurodevelopmental disorder with a birth incidence of 1:25,000. SMS is caused by haploinsufficiency of the retinoic acid-induced retinoic acid1 (RAI1) gene, determined by an interstitial deletion of ∼ 3.7 Mb (17p11.2, including the RAI1 gene) in 90 % of cases and a mutation on the RAI1 gene in only 10 % of cases. We generated and characterized a human pluripotent stem cell line (hIPSCs) derived from primary fibroblasts of a 17-year-old woman carrying a 17p11.2 deletion including the RAI1 gene., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Emergency Awake Laparotomy Using Neuraxial Anaesthesia: A Case Series and Literature Review.
- Author
-
Leoni MLG, Rossi T, Mercieri M, Cerati G, Abbott DM, Varrassi G, Cattaneo G, Capelli P, Mazzoni M, and Corso RM
- Abstract
Emergency laparotomy is a surgical procedure associated with significantly higher mortality rates compared to elective surgeries. Awake laparotomy under neuraxial anaesthesia has recently emerged as a promising approach in abdominal surgery to improve patient outcomes. This study aims to evaluate the feasibility and potential benefits of using neuraxial anaesthesia as the primary anaesthetic technique in emergency laparotomies. We conducted a case series involving 16 patients who underwent emergency laparotomy for bowel ischemia, perforation, or occlusion. Neuraxial anaesthesia was employed as the main anaesthetic technique. We analysed patient demographics, clinical characteristics, intraoperative details, and postoperative outcomes. The primary outcome measures included the adequacy of postoperative pain control, the incidence of postoperative complications, and mortality rates. Among the 16 patients, adequate postoperative pain control was achieved, with only 2 patients requiring additional analgesia. Postoperative complications, including sepsis, wound dehiscence, and pneumonia, were observed in seven patients (44%). The observed mortality rate was relatively low at 6% (one patient). Notably, conversion to general anaesthesia was not necessary in any of the cases, and no early readmissions were reported. Our findings highlight the feasibility and potential benefits of using neuraxial anaesthesia in emergency laparotomies. The observed low mortality rate and the avoidance of conversion to general anaesthesia suggest that neuraxial anaesthesia may be a useful alternative in emergency settings. However, the occurrence of postoperative complications in 44% of patients indicates the need for cautious patient selection and close monitoring. Further research with larger sample sizes is warranted to fully elucidate the efficacy, safety, and potential impact of this technique on patient outcomes in emergency laparotomies.
- Published
- 2024
- Full Text
- View/download PDF
12. Effect of different doses of camelina cake inclusion as a substitute of dietary soyabean meal on growth performance and gut health of weaned pigs.
- Author
-
Luise D, Correa F, Cestonaro G, Sattin E, Conte G, Mele M, Archetti I, Virdis S, Negrini C, Galasso I, Stefanelli C, Mazzoni M, Nataloni L, Trevisi P, and Costanzo E
- Subjects
- Animals, Swine growth & development, Animal Nutritional Physiological Phenomena, Brassicaceae chemistry, Glycine max chemistry, Gastrointestinal Microbiome drug effects, Fatty Acids, Volatile metabolism, Male, Weaning, Animal Feed analysis, Diet veterinary
- Abstract
Camelina cake (CAM) is a co-product proposed as an alternative protein source; however, piglet data are still limited. This study aimed to evaluate the effect of different doses of CAM in substitution of soyabean meal on the growth, health and gut health of weaned pigs. At 14 d post-weaning (d0), sixty-four piglets were assigned either to a standard diet or to a diet with 4 %, 8 % or 12 % of CAM. Piglets were weighed weekly. At d7 and d28, faeces were collected for microbiota and polyamine and blood for reactive oxygen metabolites (ROM) and thyroxine analysis. At d28, pigs were slaughtered, organs were weighed, pH was recorded on gut, colon was analysed for volatile fatty acids (VFA) and jejunum was used for morphological and gene expression analysis. Data analysis was carried out using a mixed model including diet, pen and litter as factors; linear and quadratic contrasts were tested. CAM linearly reduced the average daily gain from d0-d7, d0-d14, d0-d21 and d0-d28 ( P ≤ 0·01). From d0-d7 increasing CAM linearly decreased feed intake ( P = 0·04) and increased linearly the feed to gain ( P = 0·004). CAM increased linearly the liver weight ( P < 0·0001) and affected the cadaverine ( P < 0·001). The diet did not affect the ROM, thyroxine, intestinal pH, VFA and morphology. All doses of CAM increased the α diversity indices at d28 ( P < 0·05). CAM at 4 % promoted the abundance of Butyricicoccaceae_UCG-008. Feeding with CAM enhanced resilience in the gut microbiome and can be evaluated as a potential alternative protein source with dose-dependent limitations on piglet growth performance.
- Published
- 2024
- Full Text
- View/download PDF
13. Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene.
- Author
-
Ruotolo G, D'Anzi A, Casamassa A, Mazzoni M, Ferrari D, Lombardi I, Carletti RM, D'Asdia C, Torrente I, Frezza K, Lattante S, Sabatelli M, Pennuto M, Vescovi AL, and Rosati J
- Subjects
- Humans, Cell Differentiation, Fibroblasts metabolism, Cell Line, Male, Induced Pluripotent Stem Cells metabolism, C9orf72 Protein genetics, C9orf72 Protein metabolism, Amyotrophic Lateral Sclerosis genetics, Amyotrophic Lateral Sclerosis pathology, DNA Repeat Expansion
- Abstract
Genetic expansions of the hexanucleotide repeats (GGGGCC) in the C9orf72 gene appear in approximately 40% of patients with familial ALS and 7% of patients with sporadic ALS in the European population, making this mutation one of the most prevalent genetic mutations in ALS. Here, we generated a human induced pluripotent stem cell (hiPSC) line from the dermal fibroblasts of a patient carrying a 56-repeat expansion in an ALS disease-causing allele of C9orf72. These iPSCs showed stable amplification in vitro with normal karyotype and high expression of pluripotent markers and differentiated spontaneously in vivo into three germ layers., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Raman Spectroscopy on Free-Base Meso-tetra(4-pyridyl) Porphyrin under Conditions of Low Temperature and High Hydrostatic Pressure.
- Author
-
Dos Reis JRT, Leite FF, Sharma K, Ribeiro GAS, Silva WHN, Batista AA, Paschoal AR, Paraguassu W, Mazzoni M, Barbosa Neto NM, and Araujo PT
- Abstract
We present a Raman spectroscopy study of the vibrational properties of free-base meso-tetra(4-pyridyl) porphyrin polycrystals under various temperature and hydrostatic pressure conditions. The combination of experimental results and Density Functional Theory (DFT) calculations allows us to assign most of the observed Raman bands. The modifications in the Raman spectra when excited with 488 nm and 532 nm laser lights indicate that a resonance effect in the Qy band is taking place. The pressure-dependent results show that the resonance conditions change with increasing pressure, probably due to the shift of the electronic transitions. The temperature-dependent results show that the relative intensities of the Raman modes change at low temperatures, while no frequency shifts are observed. The experimental and theoretical analysis presented here suggest that these molecules are well represented by the C2v point symmetry group.
- Published
- 2024
- Full Text
- View/download PDF
15. Distribution, quantification, and characterization of substance P enteric neurons in the submucosal and myenteric plexuses of the porcine colon.
- Author
-
Mazzoni M, Cabanillas L, Costanzini A, Caremoli F, Million M, Larauche M, Clavenzani P, De Giorgio R, and Sternini C
- Subjects
- Humans, Swine, Animals, Substance P, Neurons, Colon, Choline O-Acetyltransferase, Myenteric Plexus, Submucous Plexus
- Abstract
The pig is an important translational model for studying intestinal physiology and disorders for its many homologies with humans, including the organization of the enteric nervous system (ENS), the major regulator of gastrointestinal functions. This study focused on the quantification and neurochemical characterization of substance P (SP) neurons in the pig ascending (AC) and descending colon (DC) in wholemount preparations of the inner submucosal plexus (ISP), outer submucosal plexus (OSP), and myenteric plexus (MP). We used antibodies for the pan-neuronal marker HuCD, and choline acetyltransferase (ChAT) and neuronal nitric oxide synthase (nNOS), markers for excitatory and inhibitory transmitters, for multiple labeling immunofluorescence and high-resolution confocal microscopy. The highest density of SP immunoreactive (IR) neurons was in the ISP (222/mm
2 in the AC, 166/mm2 in the DC), where they make up about a third of HuCD-IR neurons, compared to the OSP and MP (19-22% and 13-17%, respectively, P < 0.001-0.0001). HuCD/SP/ChAT-IR neurons (up to 23%) were overall more abundant than HuCD/SP/nNOS-IR neurons (< 10%). Most SP-IR neurons contained ChAT-IR (62-85%), whereas 18-38% contained nNOS-IR with the highest peak in the OSP. A subpopulation of SP-IR neurons contains both ChAT- and nNOS-IR with the highest peak in the OSP and ISP of DC (33-36%) and the lowest in the ISP of AC (< 10%, P < 0.001). SP-IR varicose fibers were abundant in the ganglia. This study shows that SP-IR neurons are functionally distinct with variable proportions in different plexuses in the AC and DC reflecting diverse functions of specific colonic regions., (© 2023. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
16. Time course evaluation of collagen type IV in Pectoralis major muscles of broiler chickens selected for different growth-rates.
- Author
-
Bordini M, Mazzoni M, Di Nunzio M, Zappaterra M, Sirri F, Meluzzi A, Petracci M, and Soglia F
- Subjects
- Humans, Animals, Pectoralis Muscles metabolism, Chickens physiology, Collagen Type IV metabolism, Muscle, Skeletal metabolism, Meat analysis, Poultry Diseases genetics, Poultry Diseases metabolism, Muscular Diseases genetics, Muscular Diseases veterinary, Muscular Diseases metabolism
- Abstract
Collagen type IV (COL4) is one of the major components of animals' and humans' basement membranes of several tissues, such as skeletal muscles and vascular endothelia. Alterations in COL4 assembly and secretion are associated to muscular disorders in humans and animals among which growth-related abnormalities such as white striping and wooden breast affecting Pectoralis major muscles (PMs) in modern fast-growing (FG) chickens. Considering the high prevalence of these myopathies in FG broilers and that a worsening is observed as the bird slaughter age is increased, the present study was intended to evaluate the distribution and the expression level of COL4 protein and its coding genes in PMs of FG broilers at different stages of muscle development (i.e., 7, 14, 21, 28, 35, and 42 d of age). Medium-growing (MG) chickens have been considered as the control group in consideration of the lower selection pressure on breast muscle growth rate and hypertrophy. Briefly, 5 PM/sampling time/genotype were selected for western blot, immunohistochemistry (IHC), and gene expression analyses. The normalized expression levels of COL4 coding genes showed an overexpression of COL4A2 in FG than MG at d 28, as well as a significant decrease in its expression over their rearing period. Overall, results obtained through the gene expression analysis suggested that selection for the hypertrophic growth of FG broilers may have led to an altered regulation of fibroblast proliferation and COL4 synthesis. Moreover, western blot and IHC analyses suggested an altered secretion and/or degradation of COL4 protein in FG broilers, as evidenced by the fluctuating trend of 2 bands observed in FG over time. In view of the above, the present research supports the evidence about a potential aberrant synthesis and/or degradation of COL4 and corroborates the hypothesis regarding a likely involvement of COL4 in the series of events underlying the growth-related abnormalities in modern FG broilers., Competing Interests: DISCLOSURES The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. Blend of natural and natural identical essential oil compounds as a strategy to improve the gut health of weaning pigs.
- Author
-
Luise D, Correa F, Negrini C, Virdis S, Mazzoni M, Dalcanale S, and Trevisi P
- Subjects
- Animals, Swine, Diet, Escherichia coli, Weaning, Diarrhea veterinary, Dietary Supplements analysis, Animal Feed analysis, Oils, Volatile pharmacology, Zinc Oxide pharmacology, Anti-Infective Agents
- Abstract
Weaning is one of the most critical phases in pig's life, often leading to postweaning diarrhoea (PWD). Zinc oxide (ZnO), at pharmacological doses, has been largely used to prevent PWD; however, due to antimicrobial co-resistant and environmental pollution issues, the EU banned its use in June 2022. Natural or natural identical components of essential oils and their mixture with organic acids are possible alternatives studied for their antimicrobial, anti-inflammatory and antioxidant abilities. This study aimed to evaluate the effect of two blends of natural or natural identical components of essential oils and organic acids compared to ZnO on health, performance, and gut health of weaned pigs. At weaning (d0), 96 piglets (7 058 ± 895 g) were assigned to one of four treatments balanced for BW and litter: CO (control treatment), ZnO (2 400 mg/kg ZnO from d0 to d14); Blend1 (cinnamaldehyde, ajowan and clove essential oils, 1 500 mg/kg feed); Blend2 (cinnamaldehyde, eugenol and short- and medium-chain fatty acids, 2 000 mg/kg feed). Pigs were weighed weekly until d35. Faeces were collected at d13 and d35 for microbiota (v3-v4 regions of the 16 s rRNA gene) and Escherichia coli (E. coli) count analysis. At d14 and d35, eight pigs/treatment were slaughtered; pH was recorded on intestinal contents and jejunal samples were collected for morphological and gene expression analysis. From d7-d14, the Blend2 had a lower average daily gain (ADG) than CO and ZnO (P < 0.05). ZnO and Blend1 never differed in ADG and feed intake. At d14, ZnO had a lower caecum pH than all other treatments. The CO treatment had a higher abundance of haemolytic E. coli than Blend1 (P = 0.01). At d13, the ZnO treatment had a lower alpha diversity (P < 0.01) and a different microbial beta diversity (P < 0.001) compared to the other treatments. At d13, the ZnO treatment was characterised by a higher abundance of Prevotellaceae_NK3B31_group (Linear Discriminant Analysis (LDA) score = 4.5, P = 0.011), Parabacteroides (LDA score = 4.5, P adj. = 0.005), the CO was characterised by Oscillospiraceae UCG-005 (LDA score = 4.3, P adj. = 0.005), Oscillospiraceae NK4A214_group (LDA score = 4.2, P adj. = 0.02), the Blend2 was characterised by Megasphaera (LDA score = 4.1, P adj. = 0.045), and Ruminococcus (LDA score = 3.9, P adj. = 0.015) and the Blend1 was characterised by Christensenellaceae_R-7_group (LDA score = 4.6, P adj. < 0.001) and Treponema (LDA score = 4.5, P adj. < 0.001). In conclusion, Blend1 allowed to maintain the gut health of postweaning piglets through modulation of the gut microbiome, the reduction of haemolytic E. coli while Blend2 did not help piglets., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
18. Occurrence and risk characterization of per- and polyfluoroalkyl substances in seafood from the Persian Gulf.
- Author
-
Akhbarizadeh R, Dobaradaran S, Mazzoni M, Pascariello S, Nabipour I, and Valsecchi S
- Subjects
- Animals, Adult, Child, Humans, Indian Ocean, Seafood analysis, Fishes, Mammals, Alkanesulfonic Acids analysis, Decapoda, Fluorocarbons analysis, Water Pollutants, Chemical analysis
- Abstract
Potential exposure to 14 per- and polyfluoroalkyl substances (PFAS) through seafood consumption was investigated in widely consumed seafood (Platycephalus indicus, Lethrinus nebulosus, and Penaeus semisulcatus) from the Persian Gulf. A total of 61 samples of fish and prawns were purchased from local fishers at Bushehr port (Persian Gulf, South-West of Iran) and were analyzed for PFAS compounds. In addition, potential factors influencing factor of PFAS bioaccumulation in fish and invertebrates such as age, sex, and habitat, were investigated. ƩPFAS concentrations were in the range of 2.3- 6.1 ng/g-d.w (mean = 3.9 ± 1.9) in studied species which are equal to 0.46-1.2 ng/g-w.w according to their conversion factor. Perfluorooctane sulfonic acid (PFOS) was the most abundant perfluorinated compound in studied organisms and tissues. The results of correlation analysis showed that the bioaccumulation of PFAS in aquatic organisms is significantly correlated to the length of the compound's carbon chain, the identity of anionic group, and organism's age, sex, and habitant. The risk assessment using hazard index calculation and Monte-Carlo simulation indicated that weekly consumption of prawn and fish fillets does not pose a health risk to adults but might threaten children's health. However, the risk posed by PFAS exposure via entire fish or fish liver intake is an important issue for wild marine mammals (i.e., dolphins). So, accurate and routine monitoring of PFAS in aquatic environments seems mandatory to preserve wildlife and human health in the Persian Gulf., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
19. Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus.
- Author
-
Spinetta R, Petrillo F, Reibaldi M, Tortori A, Mazzoni M, Metrangolo C, Gelormini F, Ricardi F, and Giordano A
- Abstract
Diabetic macular edema (DME)'s therapeutic approach can frequently be challenging. The purpose of the review is to propose evidence-based recommendations on the employment of intravitreal dexamethasone implants (DEX) when approaching patients suffering from DME. Seven national consensuses redacted by different groups of retina specialists from Europe and Asia were examined and confronted. Each consensus was redacted utilizing a Delphi approach, in person meetings, or by reviewing the literature. DEX can be studied as a first-line strategy in individuals suffering from DME with inflammatory OCT biomarkers, in vitrectomized eyes, in patients with recent cardiovascular events, in pregnant women, in patients scheduled to undergo cataract surgery or with poor compliance. The other parameters considered were the indications to the DME treatment, when to switch to DEX, the definition of non-responder to anti-VEGFs agents and to the DEX implant, whether to combine DEX with laser photocoagulation, the association between glaucoma and DEX, and the management of DEX and the cataract. Although several years have passed since the introduction of DEX implants in the DME treatment, there is still not a unified agreement among retina specialists. This paper compares the approach in the DME treatment between countries from different continents and provides a broader and worldwide perspective of the topic.
- Published
- 2023
- Full Text
- View/download PDF
20. Effects of Bioactive Peptides from Atlantic Salmon Processing By-Products on Oxyntopeptic and Enteroendocrine Cells of the Gastric Mucosa of European Seabass and Gilthead Seabream.
- Author
-
Clavenzani P, Lattanzio G, Bonaldo A, Parma L, Busti S, Oterhals Å, Romarheim OH, Aspevik T, Gatta PP, and Mazzoni M
- Abstract
The present study was designed to evaluate the effects of dietary levels of bioactive peptides (BPs) derived from salmon processing by-products on the presence and distribution of peptic cells (oxyntopeptic cells, OPs) and enteric endocrine cells (EECs) that contain GHR, NPY and SOM in the gastric mucosa of European seabass and gilthead seabream. In this study, 27 seabass and 27 seabreams were divided into three experimental groups: a control group (CTR) fed a control diet and two groups fed different levels of BP to replace fishmeal: 5% BP (BP5%) and 10% BP (BP10%). The stomach of each fish was sampled and processed for immunohistochemistry. Some SOM, NPY and GHR-IR cells exhibited alternating "open type" and "closed type" EECs morphologies. The BP10% group (16.8 ± 7.5) showed an increase in the number of NPY-IR cells compared to CTR (CTR 8.5 ± 4.8) and BP5% (BP10% vs. CTR p ≤ 0.01; BP10% vs. BP5% p ≤ 0.05) in the seabream gastric mucosa. In addition, in seabream gastric tissue, SOM-IR cells in the BP 10% diet (16.8 ± 3.5) were different from those in CTR (12.5 ± 5) (CTR vs. BP 10% p ≤ 0.05) and BP 5% (12.9 ± 2.5) (BP 5% vs. BP 10% p ≤ 0.01). EEC SOM-IR cells increased at 10% BP (5.3 ± 0.7) compared to 5% BP (4.4 ± 0.8) (5% BP vs. 10% BP p ≤ 0.05) in seabass. The results obtained may provide a good basis for a better understanding of the potential of salmon BPs as feed ingredients for seabass and seabream.
- Published
- 2023
- Full Text
- View/download PDF
21. Comparative myocardial protection of endoaortic balloon versus external clamp in minimally invasive mitral valve surgery.
- Author
-
Grazioli V, Giroletti L, Graniero A, Albano G, Mazzoni M, Panisi PG, Gerometta P, Anselmi A, and Agnino A
- Subjects
- Humans, Retrospective Studies, Minimally Invasive Surgical Procedures adverse effects, Aorta surgery, Treatment Outcome, Mitral Valve surgery, Cardiac Surgical Procedures adverse effects
- Abstract
Aims: Minimally invasive mitral valve surgery leads to shorter postoperative recovery time, cosmetic advantages and significant pain reduction compared with the standard sternotomy approach. Both an external aortic clamp and an endoaortic balloon occlusion can be used to manage the ascending aorta and the myocardial protection. In this study, we aimed to compare these two strategies in terms of effectiveness of myocardial protection and associated early postoperative outcomes., Methods: We investigated the retrospective records of prospectively collected data of patients treated by minimally invasive mitral valve surgery from March 2014 to June 2019. A total of 180 cases (78 in the external aortic clamp group and 102 in the endoaortic balloon clamp group) were collected. A propensity weighting analysis was adopted to adjust for baseline variables., Results: The endoaortic balloon clamp presented higher EuroSCORE II (higher reoperative surgery rate). The intra- and postoperative data were similar between the two groups: the postoperative troponin-I levels, peak of serum lactates and rate of myocardial infarction were also comparable. The endoaortic clamp group recorded longer operative, cardiopulmonary bypass and cross-clamp times. The external clamp group showed a higher rate of postoperative atrial fibrillation and conduction block., Conclusions: In experienced centers, the use of the endoaortic balloon clamp is safe, reproducible and comparable to the external aortic clamp regarding the effectiveness of myocardial protection: its employment might facilitate minimally invasive mitral valve surgery., (Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
22. Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring.
- Author
-
van Dijkhuizen EHP, Ridella F, Naddei R, Trincianti C, Avrusin I, Mazzoni M, Sutera D, Ayaz NA, Penades IC, Constantin T, Herlin T, Oliveira SK, Rygg M, Sanner H, Susic G, Sztajnbok F, Varbanova B, Ruperto N, Ravelli A, and Consolaro A
- Subjects
- Humans, Reproducibility of Results, Parents, Surveys and Questionnaires, Patient Reported Outcome Measures, Quality of Life, Psychometrics, Health Status, Disability Evaluation, Arthritis, Juvenile diagnosis, Arthritis, Juvenile therapy, Rheumatology
- Abstract
Objective: The aim of this work was to provide evidence of validity and reliability for 4 parent/child-reported outcome measures included in the Outcome Measures in Rheumatology juvenile idiopathic arthritis core domain set: the evaluation of the child's pain and level of disease activity, the assessment of morning stiffness duration, and an active joint count for proxy/self-assessment., Methods: Patients were included in the multinational study Epidemiology Treatment and Outcome of Childhood Arthritis. Criterion validity was assessed by examining the correlation of the 4 tested measures with physician measures and the clinical Juvenile Arthritis Disease Activity Score in 10 joints (cJADAS10) in the whole sample and after grouping patients by International League of Associations for Rheumatology (ILAR) category, geographic area, and education level. Reliability was assessed comparing 2 visits 7-14 days apart with intraclass correlation coefficients (ICCs)., Results: A total of 8,643 parents and 6,060 patients had all the evaluations available. Correlations of tested measures were moderate (0.4-0.7) with physician-reported measures. The level of correlation with the cJADAS10 remained stable after grouping patients by ILAR category, geographic areas, and level of education of the parent filling the questionnaire. In 442 parents and 344 children, ICCs ranged between 0.79 and 0.87 for parents and 0.81 and 0.88 for children., Conclusion: The 4 tested parent/child-reported outcomes showed good criterion validity and excellent reliability. These tools can be considered for remote patient assessment, when in-person evaluation might not be possible., (© 2022 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.)
- Published
- 2023
- Full Text
- View/download PDF
23. Insight into the long-term impact of birth weight on intestinal development, microbial settlement, and the metabolism of weaned piglets.
- Author
-
Trevisi P, Negrini C, Correa F, Virdis S, Laghi L, Marcello M, Conte G, Mazzoni M, and Luise D
- Subjects
- Humans, Animals, Swine, Weaning, Birth Weight, Dietary Supplements, Animal Feed analysis, Intestinal Mucosa metabolism, Eating, Jejunum
- Abstract
Infant mortality of low birth body weight (LBBW) piglets can reach 10% and is mainly due to gut and immune system immaturity which can lead to a higher risk in the long term. This study aimed to assess the impact of birth body weight (BBW) on piglet metabolism, gut status, and microbial profile from weaning to 21 d postweaning. At birth, 32 piglets were selected for their BBW and inserted into the normal BBW (NBBW:1.38 ± 0.09 g) or the LBBW (0.92 ± 0.07 g) group. The piglets were weighed weekly from weaning (d0) to d21. At d9 and d21, 8 piglets/group were slaughtered to obtain the distal jejunum for morphology, immunohistochemistry, and gene expression analysis, colon content for microbiota and short-chain fatty acid (SCFA) analysis, and intestinal content for pH measurement. Blood was collected for metabolomic, haptoglobin (Hp), and reactive oxygen metabolite (ROM) analysis. The LBBW group had a lower body weight (BW) throughout the study (P < 0.01), a lower average daily gain from d9-d21 (P = 0.002), and lower feed intake (P = 0.02). The LBBW piglets had lower Hp at d9 (P = 0.03), higher ROMs at d21 (P = 0.06), and a net alteration of the amino acid (AA) metabolism at d9 and d21. A higher expression of NFKB2 was observed in the LBBW piglets at d9 (P = 0.003) and d21 (P < 0.001). MYD88 expression was enhanced in NBBW piglets at d9 (P < 0.001). The LBBW piglets had a lower villus height, absorptive mucosal surface (P = 0.01), and villus height:crypt depth ratio (P = 0.02), and a greater number of T-lymphocytes in both the epithelium and the crypts (P < 0.001) at d21. At d21, the LBBW piglets had higher lactic acid, acetate, butyrate, and valerate, and also higher SCFA in the colon (P < 0.05). The LBBW piglets had a higher Shannon index (P = 0.01) at d9 and a higher abundance of SCFA-fermenting bacteria. In conclusion, the present study confirmed that LBBW could impact the gut mucosal structure, immunity, and inflammatory and oxidative status, leading to an altered AA metabolism, and delaying the recovery from weaning., (© The Author(s) 2023. Published by Oxford University Press on behalf of the American Society of Animal Science.)
- Published
- 2023
- Full Text
- View/download PDF
24. Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission.
- Author
-
Mazzoni M, Pistorio A, Magnaguagno F, Viola S, Urru A, Magnano GM, Ravelli A, and Malattia C
- Subjects
- Humans, Adolescent, Retrospective Studies, Symptom Flare Up, Magnetic Resonance Imaging methods, Edema diagnostic imaging, Edema epidemiology, Arthritis, Juvenile diagnostic imaging, Arthritis, Juvenile epidemiology, Arthritis, Juvenile pathology, Synovitis diagnostic imaging, Synovitis epidemiology, Bone Marrow Diseases
- Abstract
Objective: To define the prevalence of subclinical synovitis on magnetic resonance imaging (MRI) in a large cohort of patients with juvenile idiopathic arthritis (JIA) in clinical remission and to evaluate its predictive value in terms of disease flare and joint deterioration., Methods: Ninety patients with clinically inactive JIA who underwent a contrast-enhanced (CE)-MRI of a previously affected joint were retrospectively included. Each joint was evaluated for synovitis, tenosynovitis, and bone marrow edema. Baseline and follow-up radiographs were assessed to evaluate structural damage progression., Results: CE-MRI was acquired in 45 wrists, 30 hips, 13 ankles, and 2 knees. Subclinical synovitis was detected in 59 (65.5%) of 90 patients and bone marrow edema in 42 (46.7%) of 90 patients. Fifty-seven of 90 (63.3%) patients experienced a disease flare during follow-up. Forty-four of 59 (74.6%) patients with subclinical synovitis experienced a disease flare versus 13 (41.9%) of 31 patients with no residual synovitis on MRI (P = 0.002). The presence of subclinical synovitis was the best predictor of disease flare on multivariable regression analysis (hazard ratio [HR] 2.45, P = 0.003). Baseline and follow-up radiographs were available for 54 patients, and 17 (31.5%) of 54 patients experienced radiographic damage progression. The presence of bone marrow edema (HR 4.40, P = 0.045) and being >17 years old (HR 3.51, P = 0.04) were strong predictors of joint damage progression in the multivariable analysis., Conclusion: MRI-detected subclinical inflammation was present in a large proportion of patients with JIA despite clinical remission. Subclinical synovitis and bone marrow edema have been shown to play a role in predicting the risk of disease relapse and joint deterioration, with potential implications for patients' management of the disease., (© 2021 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.)
- Published
- 2023
- Full Text
- View/download PDF
25. Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.
- Author
-
Mazzoni M, Todoerti K, Agnelli L, Minna E, Pagliardini S, Di Marco T, Borrello MG, Neri A, and Greco A
- Abstract
Background: Papillary thyroid cancer (PTC) is the most frequent thyroid tumor. The tissue inhibitor of metalloproteinase-3 (TIMP3) gene encodes a matrix metalloproteinases inhibitor that exerts a tumor suppressor role in several tumor types. TIMP3 is frequently downregulated in PTC by promoter methylation. We have previously functionally demonstrated that TIMP3 exerts an oncosuppressor role in PTC: TIMP3 restoration in the PTC-derived NIM1 cell line affects in vitro migration, invasion and adhesive capability, while reduces tumor growth, angiogenesis and macrophage recruitment in vivo. To get a deeper insight on the mediators of TIMP3 oncosuppressor activity in thyroid tumors, here we focused on the TIMP3 related transcriptome., Methods: TCGA database was used for investigating the genes differentially expressed in PTC samples with low and high TIMP3 expression. Genome wide expression analysis of clones NIM1-T23 (expressing a high level of TIMP3 protein) and NIM1-EV (control empty vector) was performed. Gene sets and functional enrichment analysis with clusterProfiler were applied to identify the modulated biological processes and pathways. CIBERSORT was used to evaluate the distribution of different immunological cell types in TCGA-PTC tumor samples with different TIMP3 expression levels. Real time PCR was performed for the validation of selected genes., Results: Thyroid tumors with TIMP3-high expression showed a down-modulation of inflammation-related gene sets, along with a reduced protumoral hematopoietic cells fraction; an enrichment of cell adhesion functions was also identified. Similar results were obtained in the TIMP3-overexpessing NIM1 cells in vitro model, where a down-regulation of immune-related function gene sets, some of which also identified in tumor samples, was observed. Interestingly, through enrichment analysis, were also recognized terms related to cell adhesion, extracellular matrix organization, blood vessel maintenance and vascular process functions that have been found modulated in our previous in vitro and in vivo functional studies., Conclusions: Our results highlight the correlation of TIMP3 expression levels with the regulation of inflammatory functions and the immune infiltration composition associated with different PTC prognosis, thus providing a broader view on the oncosuppressor role of TIMP3 in PTC., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
26. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction.
- Author
-
Bianco F, Lattanzio G, Lorenzini L, Mazzoni M, Clavenzani P, Calzà L, Giardino L, Sternini C, Costanzini A, Bonora E, and De Giorgio R
- Subjects
- Humans, Chronic Disease, Intestine, Small, Intestinal Pseudo-Obstruction genetics, Intestinal Pseudo-Obstruction diagnosis, Gastrointestinal Diseases, Neuromuscular Diseases
- Abstract
Severe gut motility disorders are characterized by the ineffective propulsion of intestinal contents. As a result, the patients develop disabling/distressful symptoms, such as nausea and vomiting along with altered bowel habits up to radiologically demonstrable intestinal sub-obstructive episodes. Chronic intestinal pseudo-obstruction (CIPO) is a typical clinical phenotype of severe gut dysmotility. This syndrome occurs due to changes altering the morpho-functional integrity of the intrinsic (enteric) innervation and extrinsic nerve supply (hence neuropathy), the interstitial cells of Cajal (ICC) (mesenchymopathy), and smooth muscle cells (myopathy). In the last years, several genes have been identified in different subsets of CIPO patients. The focus of this review is to cover the most recent update on enteric dysmotility related to CIPO, highlighting (a) forms with predominant underlying neuropathy, (b) forms with predominant myopathy, and (c) mitochondrial disorders with a clear gut dysfunction as part of their clinical phenotype. We will provide a thorough description of the genes that have been proven through recent evidence to cause neuro-(ICC)-myopathies leading to abnormal gut contractility patterns in CIPO. The discovery of susceptibility genes for this severe condition may pave the way for developing target therapies for enteric neuro-(ICC)-myopathies underlying CIPO and other forms of gut dysmotility.
- Published
- 2022
- Full Text
- View/download PDF
27. Generation and characterization of CSSi016-A (9938) human pluripotent stem cell line carrying two biallelic variants in MTMR5/SBF1 gene resulting in a case of severe CMT4B3.
- Author
-
Maria Turco E, Maria Giada Giovenale A, Rotundo G, Mazzoni M, Zanfardino P, Frezza K, Torrente I, Mary Carletti R, Damiani D, Santorelli FM, Luigi Vescovi A, Petruzzella V, and Rosati J
- Subjects
- Child, Humans, Female, Cell Line, Intracellular Signaling Peptides and Proteins genetics, Pluripotent Stem Cells, Charcot-Marie-Tooth Disease genetics
- Abstract
Charcot-Marie-Tooth type 4B3 (CMT4B3) is a rare subtype of hereditary neuropathy associated with variants in the MTMR5/SBF1 gene. Herein, we report the generation and characterization of a hiPSC line from a 12-year-old Italian girl with early onset severe polyneuropathy with motor and axonal involvement, harboring biallelic variants in the MTMR5/SBF1 gene. Fibroblasts were reprogrammed using non-integrating episomal plasmids, and iPSCs successfully passed the stemness and pluripotency tests. Patient-specific hiPSCs were produced to obtain a disease model for the study of this rare condition., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
28. Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome.
- Author
-
Turco EM, Giovenale AMG, Sireno L, Mazzoni M, Cammareri A, Marchioretti C, Goracci L, Di Veroli A, Marchesan E, D'Andrea D, Falconieri A, Torres B, Bernardini L, Magnifico MC, Paone A, Rinaldo S, Della Monica M, D'Arrigo S, Postorivo D, Nardone AM, Zampino G, Onesimo R, Leoni C, Caicci F, Raimondo D, Binda E, Trobiani L, De Jaco A, Tata AM, Ferrari D, Cutruzzolà F, Mazzoccoli G, Ziviani E, Pennuto M, Vescovi AL, and Rosati J
- Subjects
- Humans, Haploinsufficiency genetics, Lipid Metabolism genetics, Transcription Factors metabolism, Trans-Activators metabolism, Phenotype, Autophagy genetics, Tretinoin pharmacology, Tretinoin metabolism, Lipids, Smith-Magenis Syndrome diagnosis, Smith-Magenis Syndrome genetics, Smith-Magenis Syndrome pathology
- Abstract
Smith-Magenis syndrome (SMS) is a neurodevelopmental disorder characterized by cognitive and behavioral symptoms, obesity, and sleep disturbance, and no therapy has been developed to alleviate its symptoms or delay disease onset. SMS occurs due to haploinsufficiency of the retinoic acid-induced-1 (RAI1) gene caused by either chromosomal deletion (SMS-del) or RAI1 missense/nonsense mutation. The molecular mechanisms underlying SMS are unknown. Here, we generated and characterized primary cells derived from four SMS patients (two with SMS-del and two carrying RAI1 point mutations) and four control subjects to investigate the pathogenetic processes underlying SMS. By combining transcriptomic and lipidomic analyses, we found altered expression of lipid and lysosomal genes, deregulation of lipid metabolism, accumulation of lipid droplets, and blocked autophagic flux. We also found that SMS cells exhibited increased cell death associated with the mitochondrial pathology and the production of reactive oxygen species. Treatment with N-acetylcysteine reduced cell death and lipid accumulation, which suggests a causative link between metabolic dyshomeostasis and cell viability. Our results highlight the pathological processes in human SMS cells involving lipid metabolism, autophagy defects and mitochondrial dysfunction and suggest new potential therapeutic targets for patient treatment., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
29. Effect of an Escherichia coli F4/F18 bivalent oral live vaccine on gut health and performance of healthy weaned pigs.
- Author
-
Correa F, Luise D, Amatucci L, Palumbo F, Virdis S, Negrini C, Clavenzani P, Vecchi M, Mazzoni M, Bosi P, and Trevisi P
- Subjects
- Swine, Animals, Weaning, Vaccines, Combined, Diet veterinary, Health Status, Animal Feed analysis, Dietary Supplements, Enterotoxigenic Escherichia coli, Escherichia coli Infections prevention & control, Escherichia coli Infections veterinary
- Abstract
Oral live vaccines stimulate host immunity, but they could also affect intestinal mucosa development and gut microbiota of piglets during the postweaning. The aim of this study was to determine the effect of an oral vaccine against Escherichia coli F4 and F18 (Coliprotec F4/F18®), on gut functionality and integrity, growth performance and health status of postweaning piglets. A total of 96 weaned piglets (23.30 ± 1.85 days of age; 7334 ± 1039 g BW) were divided into two groups (16 replicates/group; three piglets/replicate) as follows: (1) Control (CO), fed a standard diet (prestarter up to 14 days, then starter feed); (2) Treated (TRT): as CO but vaccinated with Coliprotec F4/F18® at weaning (day 0). Piglets were weighed at day 0 and weekly until day 35. Individual faecal score was recorded daily. Piglets were sacrificed at days 10 (1/3 of total) and 35 (2/3). Samples of jejunum mucosa and of cecum content were collected for morphometric, immunohistochemistry analysis and for microbiota profile analysis, respectively. Data were fitted using a linear model including treatment, class of starting BW as fixed factors and litter as random factor. From days 0 to 7, piglets from the TRT group tended to have a higher average daily gain (+22.6%, P = 0.08) and average daily feed intake compared to the CO group (+13.2%, P = 0.022). Gain to feed ratio was lower in the TRT group from days 14 to 35 (-6.6%, P = 0.011). From days 7 to 14, the TRT group had a higher diarrhoea index (-199%, P < 0.001). Crypt depth was higher in the CO group (+10.9%, P = 0.04) at day 10, but not at day 35. Jejunal expression of Claudin-4 (probability of having a score = 3) was higher in the TRT group at day 10 (CO = 1.50% vs TRT = 2.69%, P < 0.0001) and day 35 (CO = 1.29% vs TRT = 1.92%, P = 0.012). Oral vaccine affected beta diversity at day 10 (P = 0.040; R
2 = 0.05) and increased the abundance of specific taxa and genera in the cecum at day 10, including Prevotella (lg2FC = 23.2, FDR < 0.001). The results showed how an Escherichia coli-based vaccine supplied to weaned pigs can promote gut health by controlling symptoms of the postweaning perturbation in the first 2 weeks postweaning. In addition, the vaccine strains showed a probiotic-like effect by modulating gut microbiota favouring the establishment of beneficial bacteria, and by promoting gut barrier integrity., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
30. Correction: Oncogenic RAS -induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
- Author
-
Vizioli MG, Santos J, Pilotti S, Mazzoni M, Anania MC, Miranda C, Pagliardini S, Pierotti MA, Gil J, and Greco A
- Published
- 2022
- Full Text
- View/download PDF
31. Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trial.
- Author
-
Burrone M, Mazzoni M, Naddei R, Pistorio A, Spelta M, Scala S, Patrone E, Garrone M, Lombardi M, Villa L, Pascale G, Cavanna R, Ruperto N, Ravelli A, and Consolaro A
- Subjects
- Child, Humans, Injections, Intra-Articular, Methotrexate therapeutic use, Treatment Outcome, Antirheumatic Agents therapeutic use, Arthritis, Juvenile drug therapy
- Abstract
Background: Although a satisfactory disease control is nowadays achievable in most patients with JIA, a substantial proportion of them still do not respond adequately or reach long-term drug-free remission. According to current recommendations, treatment should be escalated in subsequent steps. A different approach is based on the assumption that the initial start of an aggressive therapy may take advantage of the "window of opportunity" and could alter the biology of the disease, leading to an improvement of long-term outcomes, including the prevention of cumulative joint damage., Objectives: This randomised clinical trial aims to compare the effectiveness of a conventional therapeutic regimen, based on treatment escalation and driven by the treat-to-target approach, with that of an early aggressive intervention based on the initial start of a combination of conventional and biological DMARDs., Methods: JIA patients with oligoarthritis or RF negative polyarthritis aged more than 2 years and with less than 4 months of disease course will be included in the study. Children will be randomised into two arms: patients in Step-up arm with less severe oligoarthritis will undergo an intra-articular corticosteroid injection (IACI) in all affected joints; patients with polyarthritis or severe oligoarthritis will receive IACI and methotrexate. Subsequent treatment will follow a standardised protocol based on the patients' level of disease activity measured with the JADAS, according to a treat-to-target strategy. Patients in Step-down arm will receive a 6-month early combined treatment (methotrexate plus IACI for less severe oligoarthritis, methotrexate plus etanercept for severe oligoarthritis and polyarthritis). The primary endpoint is the frequency of achievement of the status of clinical remission (i.e. persistence of inactive disease for at least 6 months) at the 12-month visit. Safety events, physician-centred measures and parent/patient-reported outcomes will be collected through the Paediatric Rheumatology International Trials Organisation on line database., Expected Results: The STARS trial aims to provide important evidence supporting the first-line treatment choices in the care of children with oligoarticular and polyarticular JIA. If the superiority of an early aggressive therapy will be demonstrated, this will demand further studies on the biological definition of the window of opportunity for JIA., Trial Registration: The Trial is registered on the ClinicalTrials.gov registry (NCT03728478) on the 31st October 2018 and EU Clinical Trials Register on the 14th May 2018 (EudraCT Number: 2018-001931-27)., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
32. The evolution of vimentin and desmin in Pectoralis major muscles of broiler chickens supports their essential role in muscle regeneration.
- Author
-
Soglia F, Bordini M, Mazzoni M, Zappaterra M, Di Nunzio M, Clavenzani P, Davoli R, Meluzzi A, Sirri F, and Petracci M
- Abstract
Vimentin (VIM) and desmin (DES) are muscle-specific proteins having crucial roles in maintaining the lateral organization and alignment of the sarcomeric structure during myofibrils' regeneration. The present experiment was designed to ascertain the evolution of VIM and DES in Pectoralis major muscles (PM) of fast-growing (FG) and medium-growing (MG) meat-type chickens both at the protein and gene levels. MG broilers were considered as a control group whereas the evolution of VIM and DES over the growth period was evaluated in FG by collecting samples at different developmental stages (7, 14, 21, 28, 35, and 42 days). After performing a preliminary classification of the samples based on their histological features, 5 PM/sampling time/genotype were selected for western blot, immunohistochemistry (IHC), and gene expression analyses. Overall, the findings obtained at the protein level mirrored those related to their encoding genes, although a potential time lag required to observe the consequences of gene expression was evident. The two- and 3-fold higher level of the VIM-based heterodimer observed in FG at d 21 and d 28 in comparison with MG of the same age might be ascribed to the beginning and progressive development of the regenerative processes. This hypothesis is supported by IHC highlighting the presence of fibers to co-expressing VIM and DES. In addition, gene expression analyses suggested that, unlike VIM common sequence, VIM long isoform may not be directly implicated in muscle regeneration. As for DES content, the fluctuating trends observed for both the native protein and its heterodimer in FG might be ascribed to its importance for maintaining the structural organization of the regenerating fibers. Furthermore, the higher expression level of the DES gene in FG in comparison with MG further supported its potential application as a marker of muscle fibers' regeneration. In conclusion, the findings of the present research seem to support the existence of a relationship between the occurrence of muscle regeneration and the growth rate of meat-type chickens and corroborate the potential use of VIM and DES as molecular markers of these cellular processes., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Soglia, Bordini, Mazzoni, Zappaterra, Di Nunzio, Clavenzani, Davoli, Meluzzi, Sirri and Petracci.)
- Published
- 2022
- Full Text
- View/download PDF
33. Electronic Nose for the Rapid Detection of Deoxynivalenol in Wheat Using Classification and Regression Trees.
- Author
-
Camardo Leggieri M, Mazzoni M, Bertuzzi T, Moschini M, Prandini A, and Battilani P
- Subjects
- Electronic Nose, Food Contamination analysis, Oxides, Trichothecenes, Triticum, Fusarium, Mycotoxins analysis
- Abstract
Mycotoxin represents a significant concern for the safety of food and feed products, and wheat represents one of the most susceptible crops. To manage this issue, fast, reliable, and low-cost test methods are needed for regulated mycotoxins. This study aimed to assess the potential use of the electronic nose for the early identification of wheat samples contaminated with deoxynivalenol (DON) above a fixed threshold. A total of 214 wheat samples were collected from commercial fields in northern Italy during the periods 2014−2015 and 2017−2018 and analyzed for DON contamination with a conventional method (GC-MS) and using a portable e-nose “AIR PEN 3” (Airsense Analytics GmbH, Schwerin, Germany), equipped with 10 metal oxide sensors for different categories of volatile substances. The Machine Learning approach “Classification and regression trees” (CART) was used to categorize samples according to four DON contamination thresholds (1750, 1250, 750, and 500 μg/kg). Overall, this process yielded an accuracy of >83% (correct prediction of DON levels in wheat samples). These findings suggest that the e-nose combined with CART can be an effective quick method to distinguish between compliant and DON-contaminated wheat lots. Further validation including more samples above the legal limits is desirable before concluding the validity of the method.
- Published
- 2022
- Full Text
- View/download PDF
34. Effect of chronic heat stress on gastrointestinal histology and expression of feed intake-regulatory hormones in broiler chickens.
- Author
-
Mazzoni M, Zampiga M, Clavenzani P, Lattanzio G, Tagliavia C, and Sirri F
- Subjects
- Animal Feed analysis, Animals, Cholecystokinin metabolism, Eating, Glucagon-Like Peptide 1 metabolism, Heat-Shock Response, Hot Temperature, Male, Serotonin metabolism, Chickens physiology, Heat Stress Disorders veterinary
- Abstract
Heat stress (HS) dramatically impairs the growth performance of broiler chickens, mainly as a consequence of reduced feed intake due to the loss of appetite. This study was aimed at evaluating the alterations induced by chronic HS conditions on the morphological and morphometric features of the gastrointestinal (GI) tract and on the expression of some enteroendocrine cells (EECs) involved in the regulation of feed intake in chickens. Three hundred male chickens (Ross 308) were divided into two experimental groups and raised either in thermoneutral environment for the whole fattening period (0-41 days) (TNT group) or subjected to chronic HS conditions (30 °C for 24 h/day) from 35 to 41 days (HS group). Samples of proventriculus, duodenum, jejunum and cecum were collected from 24 broilers (12/group). Haematoxylin-eosin was used for the morphometric evaluations, while immunohistochemistry was applied for the evaluation of EECs expressing ghrelin (GHR), cholecystokinin (CCK), neuropeptide Y (NPY), glucagon-like peptide-1 (GLP-1), and serotonin (5-HT). In the proventriculus, HS reduced total wall thickness and mucous layer height (P ≤ 0.01) as well as mean diameter, circumference, and area of the compound tubular glands (P ≤ 0.001) with respect to TNT. The small intestine of HS birds was characterised by decreased villous height and total thickness (duodenum, P ≤ 0.01; jejunum, P ≤ 0.001), whereas crypt depth and width were reduced only in the jejunum (P ≤ 0.01). HS had negligible effects on the morphological aspects of the cecum. In the proventriculus, an increase in GHR and NPY EECs was observed in response to HS (P ≤ 0.001). Similarly, the small intestine villi of the HS group showed greater GLP-1 (P ≤ 0.05), 5-HT (P ≤ 0.001) and CCK (P ≤ 0.01) EECs. Moreover, the expression of 5-HT EECs was higher in the duodenal (P ≤ 0.01) and jejunal (P ≤ 0.01) crypts of HS birds, whereas GLP-1 and CCK EECs increased only in jejunal crypts (P ≤ 0.05). Finally, 5-HT EEC expression was increased in the cecum of HS group (P ≤ 0.01). In conclusion, these outcomes demonstrate that chronic HS induces morphometric alterations not only in the small intestine but also in a key organ such as the proventriculus. Furthermore, HS conditions affect the presence and distribution of EECs, suggesting that some GI peptides and biogenic amine may be implicated in the regulation of appetite and voluntary feed intake in heat-stressed broiler chickens., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
35. Clinical and Pathological Features of Severe Gut Dysmotility.
- Author
-
Bianco F, Bonora E, Lattanzio G, Clavenzani P, Guarino M, Mazzoni M, Baldassarro VA, Lorenzini L, Caio G, Stanghellini V, Sternini C, Farrugia G, Giardino L, Calzà L, and De Giorgio R
- Subjects
- Humans, Intestine, Small, Mutation, Chronic Disease, Gastrointestinal Motility genetics, Intestinal Pseudo-Obstruction genetics, Intestinal Pseudo-Obstruction diagnosis
- Abstract
Severe gut motility disorders are characterized by ineffective propulsion of intestinal contents. As a result, patients often develop extremely uncomfortable symptoms, ranging from nausea and vomiting along with alterations of bowel habits, up to radiologically confirmed subobstructive episodes. Chronic intestinal pseudo-obstruction (CIPO) is a typical clinical phenotype of severe gut dysmotility due to morphological and functional alterations of the intrinsic (enteric) innervation and extrinsic nerve supply (hence neuropathy), interstitial cells of Cajal (ICCs) (mesenchymopathy), and smooth muscle cells (myopathy). In this chapter, we highlight some molecular mechanisms of CIPO and review the clinical phenotypes and the genetics of the different types of CIPO. Specifically, we will detail the role of some of the most representative genetic mutations involving RAD21, LIG3, and ACTG2 to provide a better understanding of CIPO and related underlying neuropathic or myopathic histopathological abnormalities. This knowledge may unveil targeted strategies to better manage patients with such severe disease., (© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.)
- Published
- 2022
- Full Text
- View/download PDF
36. Accumulation of Selected Trace Elements in Shads from Three Lakes: First Insights from Italian Pre-Alpine Area.
- Author
-
Boldrocchi G, Monticelli D, Mazzoni M, Spanu D, and Bettinetti R
- Subjects
- Animals, Ecosystem, Environmental Monitoring, Fishes, Food Chain, Italy, Lakes, Trace Elements analysis, Water Pollutants, Chemical analysis
- Abstract
The investigation of trace element pollution is important for the environmental assessment and management of lacustrine ecosystems, especially when these represent critical freshwater resources in densely populated areas. In this context, this study determined the levels of 15 trace elements in muscles of shad, Alosa agone (Scopoli 1786), a commercialized zooplanktivourous fish, from three primary, but currently still poorly studied, Italian lakes, namely, Lake Como, Iseo, and Garda. Research findings show that shads present similar trace element accumulation patterns among lakes, except for arsenic, which occurs at lower levels in Lake Como. Results provide evidence also for mercury biomagnification in fish, whereas all the other selected trace elements undergo bio-dilution through the same trophic chain. Maximum allowable limits for foodstuff were exceeded for chromium and selenium in shads, whereas mercury levels exceeded the European Environmental Quality Standard biota. These results highlight the need for regular monitoring activities of trace elements in the biota of these lakes., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
37. Effect of Essential Oils on the Oxyntopeptic Cells and Somatostatin and Ghrelin Immunoreactive Cells in the European Sea Bass ( Dicentrarchus labrax ) Gastric Mucosa.
- Author
-
Mazzoni M, Lattanzio G, Bonaldo A, Tagliavia C, Parma L, Busti S, Gatta PP, Bernardi N, and Clavenzani P
- Abstract
The current work was designed to assess the effect of feed supplemented with essential oils (EOs) on the histological features in sea bass's gastric mucosa. Fish were fed three diets: control diet (CTR), HERBAL MIX
® made with natural EOs (N-EOs), or HERBAL MIX® made with artificial EOs obtained by synthesis (S-EOs) during a 117-day feeding trial. Thereafter, the oxyntopeptic cells (OPs) and the ghrelin (GHR) and somatostatin (SOM) enteroendocrine cells (EECs) in the gastric mucosa were evaluated. The Na+ K+ -ATPase antibody was used to label OPs, while, for the EECs, anti-SOM and anti-GHR antibody were used. The highest density of OP immunoreactive (IR) area was in the CTR group (0.66 mm2 ± 0.1). The OP-IR area was reduced in the N-EO diet group (0.22 mm2 ± 1; CTR vs. N-EOs, p < 0.005), while in the S-EO diet group (0.39 mm2 ± 1) a trend was observed. We observed an increase of the number of SOM-IR cells in the N-EO diet (15.6 ± 4.2) compared to that in the CTR (11.8 ± 3.7) (N-EOs vs. CTR; p < 0.05), but not in the S-EOs diet. These observations will provide a basis to advance current knowledge on the anatomy and digestive physiology of this species in relation to pro-heath feeds.- Published
- 2021
- Full Text
- View/download PDF
38. Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility.
- Author
-
Bianco F, Lattanzio G, Lorenzini L, Diquigiovanni C, Mazzoni M, Clavenzani P, Calzà L, Giardino L, Sternini C, Bonora E, and De Giorgio R
- Subjects
- Animals, Gastrointestinal Motility physiology, Humans, Intestinal Diseases physiopathology, Intestinal Pseudo-Obstruction physiopathology, Mitochondrial Diseases genetics, Mitochondrial Diseases physiopathology, Mutation, Neurons physiology, Gastrointestinal Motility genetics, Intestinal Diseases genetics, Intestinal Pseudo-Obstruction genetics
- Abstract
The enteric nervous system (ENS) is the third division of the autonomic autonomic nervous system and the largest collection of neurons outside the central nervous system (CNS). The ENS has been referred to as "the brain in the gut" or "the second brain of the human body" because of its highly integrated neural circuits controlling a vast repertoire of gut functions, including absorption/secretion, splanchnic blood vessels, some immunological aspects, intestinal epithelial barrier, and gastrointestinal (GI) motility. The latter function is the result of the ENS fine-tuning over smooth musculature, along with the contribution of other key cells, such as enteric glia (astrocyte like cells supporting and contributing to neuronal activity), interstitial cells of Cajal (the pacemaker cells of the GI tract involved in neuromuscular transmission), and enteroendocrine cells (releasing bioactive substances, which affect gut physiology). Any noxa insult perturbing the ENS complexity may determine a neuropathy with variable degree of neuro-muscular dysfunction. In this review, we aim to cover the most recent update on genetic mechanisms leading to enteric neuropathies ranging from Hirschsprung's disease (characterized by lack of any enteric neurons in the gut wall) up to more generalized form of dysmotility such as chronic intestinal pseudo-obstruction (CIPO) with a significant reduction of enteric neurons. In this line, we will discuss the role of the RAD21 mutation, which we have demonstrated in a family whose affected members exhibited severe gut dysmotility. Other genes contributing to gut motility abnormalities will also be presented. In conclusion, the knowledge on the molecular mechanisms involved in enteric neuropathy may unveil strategies to better manage patients with neurogenic gut dysmotility and pave the way to targeted therapies.
- Published
- 2021
- Full Text
- View/download PDF
39. Bioaccumulation and biomagnification in elasmobranchs: A concurrent assessment of trophic transfer of trace elements in 12 species from the Indian Ocean.
- Author
-
Boldrocchi G, Spanu D, Mazzoni M, Omar M, Baneschi I, Boschi C, Zinzula L, Bettinetti R, and Monticelli D
- Subjects
- Animals, Bioaccumulation, Environmental Monitoring, Food Chain, Indian Ocean, Sharks, Trace Elements analysis, Water Pollutants, Chemical analysis
- Abstract
We provided the first multi-species study investigating the presence and organotropism of trace elements in three tissues of 12 elasmobranch species. Shark species showed comparable TE loads, although milk sharks and juvenile scalloped hammerhead sharks exhibited the highest Cd and Hg levels, respectively. Fins accumulated higher levels of Pb, Co, and Cr; muscles higher V, As, and Hg; livers higher Se and Cd levels. The organotropism of TEs calls for cautious when choosing a tissue to be sampled since certain tissues, like fin clips, do not provide reliable surrogate for the internal loads of some TEs. Strong correlations between essential and toxic TEs indicated detoxification mechanisms, while the TMF provided evidence for Hg, As and Se biomagnification along the food-web. Considering the difficulties in assessing elasmobranchs contamination from different areas, the proposed multi-species approach represents a valuable way to estimate the species-specific accumulation and transfer of pollutants in sharks., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
40. Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept-A Case Report.
- Author
-
Mazzoni M, Dell'Orso G, Grossi A, Ceccherini I, Viola S, Terranova P, Micalizzi C, Guardo D, Massaccesi E, Palmisani E, Calvillo M, Fioredda F, Malattia C, Dufour C, Ravelli A, and Miano M
- Subjects
- Adolescent, Arthritis, Juvenile complications, Arthritis, Juvenile pathology, Autoimmune Lymphoproliferative Syndrome complications, Autoimmune Lymphoproliferative Syndrome pathology, CTLA-4 Antigen genetics, Female, Humans, Prognosis, Abatacept therapeutic use, Arthritis, Juvenile drug therapy, Autoimmune Lymphoproliferative Syndrome drug therapy, CTLA-4 Antigen deficiency, Immune Checkpoint Inhibitors therapeutic use, Mutation
- Abstract
Background: Functional variants of the cytotoxic T-lymphocyte antigen-4 (CTLA4) could contribute to the pathogenesis of disorders characterized by abnormal T-cell responses., Case Presentation: We report a case of a 13-year-old girl who first presented with polyarticular juvenile idiopathic arthritis poorly responsive to treatment. During the following years the patient developed cytopenias, chronic lymphoproliferation, high values of T-cell receptor αβ+ CD4- CD8- double-negative T cells and defective Fas-mediated T cells apoptosis. Autoimmune lymphoproliferative syndrome was diagnosed and therapy with mycophenolate mofetil was started, with good hematological control. Due to the persistence of active polyarthritis, mycophenolate mofetil was replaced with sirolimus. In the following months the patient developed hypogammaglobulinemia and started having severe diarrhea. Histologically, duodenitis and chronic gastritis were present. Using the next generation sequencing-based gene panel screening, a CTLA4 mutation was detected (p.Cys58Serfs*13). At the age of 21 the patient developed acute autoimmune hemolytic anemia; steroid treatment in combination with abatacept were started with clinical remission of all symptoms, even arthritis., Conclusions: Targeted immunologic screening and appropriate genetic tests could help in the diagnosis of a specific genetically mediated immune dysregulation syndrome, allowing to select those patients who can take advantage of target therapy, as in the case of abatacept in CTLA4 deficiency., Competing Interests: The authors declare no conflict of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
41. Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.
- Author
-
Trincianti C, Van Dijkhuizen EHP, Alongi A, Mazzoni M, Swart JF, Nikishina I, Lahdenne P, Rutkowska-Sak L, Avcin T, Quartier P, Panaviene V, Uziel Y, Pruunsild C, Vargova V, Vilaiyuk S, Dolezalova P, Ringold S, Garrone M, Ruperto N, Ravelli A, and Consolaro A
- Subjects
- Arthritis, Juvenile blood, Child, Humans, Registries, Rheumatoid Factor blood, Severity of Illness Index, Arthritis, Juvenile diagnosis, Rheumatology
- Abstract
Objective: To develop and validate new Juvenile Arthritis Disease Activity Score 10 (JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive disease (ID), minimal disease activity (MiDA), moderate disease activity (MoDA), and high disease activity (HDA) in children with oligoarthritis and with rheumatoid factor-negative polyarthritis, based on subjective disease assessment by the treating pediatric rheumatologist., Methods: The cutoffs definition cohort was composed of 1,936 patients included in the multinational Epidemiology, Treatment and Outcome of Childhood Arthritis (EPOCA) study. Using the subjective physician rating as an external criterion, 4 methods were applied to identify the cutoffs: mapping, Youden index, 90% specificity, and maximum agreement. The validation cohort included 4,014 EPOCA patients, patients from 2 randomized trials, and 88 patients from the PharmaChild registry. Cutoff validation was conducted by assessing discriminative and predictive ability., Results: The JADAS10 cutoffs were 1.4, 4, and 13, respectively, for oligoarthritis and 2.7, 6, and 17, respectively, for polyarthritis. The cJADAS10 cutoffs were 1.1, 4, and 12, respectively, for oligoarthritis and 2.5, 5, and 16, respectively, for polyarthritis. The cutoffs discriminated strongly among different levels of pain and morning stiffness, between patients who were and those who were not prescribed a new medication, and between different levels of improvement in clinical trials. Achievement of ID and MiDA according to the new JADAS cutoffs at least twice in the first year of disease predicted better outcome at 2 years., Conclusion: The 2021 JADAS and cJADAS cutoffs revealed good metrologic properties in both definition and validation samples, and are therefore suitable for use in clinical trials and routine practice., (© 2021 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.